Fred Hutchinson Cancer Research Center Clinical Research DirectorAppointed: 1993 Seattle Cancer Care Alliance Executive DirectorAppointed: 1998 University of Washington School of Medicine Medicine Head, Division of Medical OncologyAppointed: 1998 Fred Hutchinson Cancer Research Center Clinical Research MemberAppointed: 1988 University of Washington School of Medicine Medical Oncology ProfessorAppointed: 1988 |  |
QualificationsM.D., Tufts University, 1972. A.B. (cum laude), Dartmouth College, 1968. Expertise and Research InterestsOur group is interested in developing an improved understanding of the biology of acute myeloid leukemia (AML) and using this knowledge to create novel therapeutic approaches. The following are several examples of such studies: (1) In one group of studies, we had previously shown that higher dose total body irradiation given in conjunction with hematopoietic cell transplantation was able to more reliably eradicate AML, but was associated with increased transplant-related toxicities. We have since shown the feasibility of targeting radiation therapy specifically to sites of normal and abnormal hematopoiesis using monoclonal antibodies against CD45 radiolabeled with 131I, and phase II trials incorporating this approach in transplant preparative regimens have yielded encouraging results. Current studies are aimed at further improving the specificity of targeting radiotherapy and defining the optimal way to apply this technique. (2) In a second group of experiments, we found that following exposure to cell-damaging agents, AML cells dramatically increase cellular cholesterol content and that blocking this response specifically sensitizes cells to chemotherapy. Subsequent clinical trials have demonstrated the feasibility of adding high dose pravastatin to leukemia induction therapy with encouraging clinical outcomes. We are currently attempting to conclusively define the role of cholesterol synthesis blockade in AML treatment. (3) In collaboration with the Southwest Oncology group, we have found that MDR1 mediated drug efflux in AML is increased in older patients and in patients with recurrent disease, and is tightly associated with drug resistance. We have completed studies showing an advantage of the use of MDR1 inhibition in patients with recurrent AML and are currently conducting clinical trials in the up-front treatment of older patients. In addition, we have identified novel compounds that inhibit not only drug efflux but the effects of BCL-2 overexpression and are attempting to define the optimal way in which to apply such therapy.
Banker, D.E., Mayer, S.J., Li, H.Y., Willman, C.L., Appelbaum, F.R., Zager, R.A. Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells. Blood 104: 1816-1824, 2004.
Appelbaum,F.R., Gundacker,H., Head,D.R., Slovak,M.L., Willman,C.L., Godwin,J.E., Anderson,J.E., Petersdorf,S.H. Age and acute myeloid leukemia. Blood 107:3481-3485, 2006.
Larson,R.A., Sievers,E.L., Stadtmauer,E.A., Löwenberg,B., Estey,E.H., Dombret,H., Theobald,M., Voliotis,D., Bennett,J.M., Richie,M., Leopold,L.H., Berger,M.S., Sherman,M.L., Loken,M.R., van Dongen,J.J.M., Bernstein,I.D., Appelbaum,F.R. Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence. Cancer 104: 1442-1452, 2005.
Pagel,J.M., Appelbaum,F.R., Eary,J.F., Rajendran,J., Fisher,D.R., Gooley,T., Ruffner,K., Nemecek,E., Sickle,E., Durack,L., Carreras,J., Horowitz,M.M., Press,O.W., Gopal,A.K., Martin,P.J., Bernstein,I.D., Matthews,D.C. 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission. Blood 107: 2184-2191, 2006.
Walter,R.B., Pirga,J.L., Cronk,M.R., Mayer,S., Appelbaum,F.R., Banker,D.E. PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism. Blood 106: 3584-3593, 2005. Other ExpertiseIn addition to overseeing a laboratory focused on the biology of acute myeloid leukemia and chairing the Leukemia Committee of the Southwest Oncology Group, Dr. Appelbaum is the head of the Program in Clinical Transplant Research at the Fred Hutchinson Cancer Research Center. The overall goal of the Program in Clinical Transplant Research is to improve the therapy of cancer in children and adults through the conduct of clinical trials, many of which involve marrow and stem cell transplantation. Major topics of these trials include the eradication of malignancy, control of graft-vs-host disease, and prevention of transplant related complications. KeywordsCOS Keywords:Cancer Biology, Leukemia, Oncology, Radiobiology, Tumors.Additional Terms:Cancer, Oncology, Tumor Biology.MembershipsAlpha Omega Alpha American Association for Cancer Research American Society of Clinical Oncology American Society of Hematology International Society for Experimental Hematology Publications- Stirewalt DL, Choi YE, Sharpless NE, Pogosova-Agadjanyan EL, Cronk MR, Yukawa M, Larson EB, Wood BL, Appelbaum FR, Radich JP, Heimfeld S (Feb 2009) Decreased IRF8 expression found in aging hematopoietic progenitor/stem cells., Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, 23 (2), 430
 - Stirewalt DL, Choi YE, Sharpless NE, Pogosova-Agadjanyan EL, Cronk MR, Yukawa M, Larson EB, Wood BL, Appelbaum FR, Radich JP, Heimfeld S (Feb 2009) Decreased IRF8 expression found in aging hematopoietic progenitor/stem cells., Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, 23 (2), 391-393
 - Pagel JM, Matthews DC, Kenoyer A, Hamlin DK, Wilbur DS, Fisher DR, Gopal AK, Lin Y, Saganic L, Appelbaum FR, Press OW (Jan 2009) Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemia., Cancer research, 69 (1), 185-92
 - Becker PS, Kopecky KJ, Wilks AN, Chien S, Harlan JM, Willman CL, Petersdorf SH, Stirewalt DL, Papayannopoulou T, Appelbaum FR (Jan 2009) Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia., Blood, 113 (4), 866-74
 - Sanders JE, Hoffmeister PA, Woolfrey AE, Carpenter PA, Storer BE, Storb RF, Appelbaum FR (Jan 2009) Thyroid function following hematopoietic cell transplantation in children: 30 years' experience., Blood, 113 (2), 306-8
 - Appelbaum FR (Dec 2008) What is the impact of hematopoietic cell transplantation (HCT) for older adults with acute myeloid leukemia (AML)?, Best practice & research. Clinical haematology, 21 (4), 667-75
 - Flowers ME, Storer B, Carpenter P, Rezvani AR, Vigorito AC, Campregher PV, Moravec C, Kiem HP, Fero M, Georges G, Warren E, Lee S, Sanders JE, Appelbaum F, Martin PJ (Dec 2008) Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease., Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 14 (12), 1380-4
 - O'Donnell MR, Appelbaum FR, Coutre SE, Damon LE, Erba HP, Foran J, Lancet J, Maness LJ, Marcucci G, Maslak PG, Millenson M, Moore JO, Ravandi F, Schuening F, Shami P, Smith BD, Stone RM, Tallman MS, Wang E, White FL (Nov 2008) Acute myeloid leukemia., Journal of the National Comprehensive Cancer Network : JNCCN, 6 (10), 962-93
 - Rotta M, Storer BE, Sahebi F, Shizuru JA, Bruno B, Lange T, Agura ED, McSweeney PA, Pulsipher MA, Hari P, Maziarz RT, Chauncey TR, Appelbaum FR, Sorror ML, Bensinger W, Sandmaier BM, Storb RF, Maloney DG (Nov 2008) Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting., Blood
 - Mielcarek M, Storer BE, Boeckh MJ, Carpenter PA, McDonald GB, Deeg HJ, Nash RA, Flowers ME, Doney K, Lee S, Marr KA, Furlong T, Storb R, Appelbaum FR, Martin PJ (Nov 2008) Initial therapy of acute graft-versus-host disease with "low-dose" prednisone does not compromise patient outcomes., Blood
 - Woolfrey AE, Malhotra U, Harrington RD, McNevin J, Manley TJ, Riddell SR, Coombs RW, Appelbaum FR, Corey L, Storb R (Oct 2008) Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation., Blood, 112 (8), 3484-7
 - Doney K, Loken M, Bryant E, Smith A, Appelbaum F (Aug 2008) Lack of utility of chimerism studies obtained 2-3 months after myeloablative hematopoietic cell transplantation for ALL., Bone marrow transplantation, 42 (4), 271-4
 - Scott BL, Park JY, Deeg HJ, Marr KA, Boeckh M, Chauncey TR, Appelbaum FR, Storb R, Storer BE (Jul 2008) Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes., Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 14 (7), 799-806
 - Appelbaum FR (Jun 2008) Hematopoietic cell transplantation for non-Hodgkin's lymphoma: yesterday, today, and tomorrow., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 (18), 2927-9
 - Walter RB, Boyle KM, Appelbaum FR, Bernstein ID, Pagel JM (May 2008) Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenografts., Blood, 111 (9), 4813-6
 - Appelbaum FR (Mar 2008) Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML)., Best practice & research. Clinical haematology, 21 (1), 85-92
 - Pullarkat V, Slovak ML, Kopecky KJ, Forman SJ, Appelbaum FR (Mar 2008) Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study., Blood, 111 (5), 2563-72
 - Pagel JM, Hedin N, Drouet L, Wood BL, Pantelias A, Lin Y, Hamlin DK, Wilbur DS, Gopal AK, Green D, Appelbaum FR, Press OW (Feb 2008) Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy., Blood, 111 (4), 2261-8
 - Oliansky DM, Appelbaum F, Cassileth PA, Keating A, Kerr J, Nieto Y, Stewart S, Stone RM, Tallman MS, McCarthy PL, Hahn T (Feb 2008) The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review., Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 14 (2), 137-80
 - Appelbaum FR (2008) Allogeneic hematopoietic cell transplantation for acute myeloid leukemia when a matched related donor is not available., Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2008, 412-7
 - Petersdorf SH, Rankin C, Head DR, Terebelo HR, Willman CL, Balcerzak SP, Karnad AB, Dakhil SR, Appelbaum FR (Dec 2007) Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500)., American journal of hematology, 82 (12), 1056-62
 - Sorror ML, Giralt S, Sandmaier BM, De Lima M, Shahjahan M, Maloney DG, Deeg HJ, Appelbaum FR, Storer B, Storb R (Dec 2007) Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences., Blood, 110 (13), 4606-13
 - Ferrara JL, Anasetti C, Stadtmauer E, Antin J, Wingard J, Lee S, Levine J, Schultz K, Appelbaum F, Negrin R, Giralt S, Bredeson C, Heslop H, Horowitz M (Nov 2007) Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007., Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 13 (11), 1268-85
 - Appelbaum FR (Oct 2007) Hematopoietic-cell transplantation at 50., The New England journal of medicine, 357 (15), 1472-5
 - Sorror ML, Sandmaier BM, Storer BE, Maris MB, Baron F, Maloney DG, Scott BL, Deeg HJ, Appelbaum FR, Storb R (Sep 2007) Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 (27), 4246-54
 - Chang C, Storer BE, Scott BL, Bryant EM, Shulman HM, Flowers ME, Sandmaier BM, Witherspoon RP, Nash RA, Sanders JE, Bedalov A, Hansen JA, Clurman BE, Storb R, Appelbaum FR, Deeg HJ (Aug 2007) Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic d, Blood, 110 (4), 1379-87
 - Riddell SR, Appelbaum FR (Jul 2007) Graft-versus-host disease: a surge of developments., PLoS medicine, 4 (7), e198
 - DeAngelo DJ, Yu D, Johnson JL, Coutre SE, Stone RM, Stopeck AT, Gockerman JP, Mitchell BS, Appelbaum FR, Larson RA (Jun 2007) Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801., Blood, 109 (12), 5136-42
 - Walter RB, Gooley TA, van der Velden VH, Loken MR, van Dongen JJ, Flowers DA, Bernstein ID, Appelbaum FR (May 2007) CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy., Blood, 109 (10), 4168-70
 - Carpenter PA, Snyder DS, Flowers ME, Sanders JE, Gooley TA, Martin PJ, Appelbaum FR, Radich JP (Apr 2007) Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia., Blood, 109 (7), 2791-3
 - Kornblau SM, Banker DE, Stirewalt D, Shen D, Lemker E, Verstovsek S, Estrov Z, Faderl S, Cortes J, Beran M, Jackson CE, Chen W, Estey E, Appelbaum FR (Apr 2007) Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study., Blood, 109 (7), 2999-3006
 - Gopal AK, Rajendran JG, Gooley TA, Pagel JM, Fisher DR, Petersdorf SH, Maloney DG, Eary JF, Appelbaum FR, Press OW (Apr 2007) High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 (11), 1396-402
 - Appelbaum FR, Rosenblum D, Arceci RJ, Carroll WL, Breitfeld PP, Forman SJ, Larson RA, Lee SJ, Murphy SB, O'Brien S, Radich J, Scher NS, Smith FO, Stone RM, Tallman MS (Mar 2007) End points to establish the efficacy of new agents in the treatment of acute leukemia., Blood, 109 (5), 1810-6
 - Grever MR, Lucas DM, Dewald GW, Neuberg DS, Reed JC, Kitada S, Flinn IW, Tallman MS, Appelbaum FR, Larson RA, Paietta E, Jelinek DF, Gribben JG, Byrd JC (Mar 2007) Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 (7), 799-804
 - Flinn IW, Neuberg DS, Grever MR, Dewald GW, Bennett JM, Paietta EM, Hussein MA, Appelbaum FR, Larson RA, Moore DF, Tallman MS (Mar 2007) Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 (7), 793-8
 - Scott BL, Storer BE, Greene JE, Hackman RC, Appelbaum FR, Deeg HJ (Mar 2007) Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasia., Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 13 (3), 345-54
 - Kerbauy DM, Gooley TA, Sale GE, Flowers ME, Doney KC, Georges GE, Greene JE, Linenberger M, Petersdorf E, Sandmaier BM, Scott BL, Sorror M, Stirewalt DL, Stewart FM, Witherspoon RP, Storb R, Appelbaum FR, Deeg HJ (Mar 2007) Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia., Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 13 (3), 355-65
 - Appelbaum FR (Mar 2007) Hematopoietic cell transplantation from unrelated donors for treatment of patients with acute myeloid leukemia in first complete remission., Best practice & research. Clinical haematology, 20 (1), 67-75
 - Oehler VG, Gooley T, Snyder DS, Johnston L, Lin A, Cummings CC, Chu S, Bhatia R, Forman SJ, Negrin RS, Appelbaum FR, Radich JP (Feb 2007) The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia., Blood, 109 (4), 1782-9
 - Appelbaum FR, Kopecky KJ, Tallman MS, Slovak ML, Gundacker HM, Kim HT, Dewald GW, Kantarjian HM, Pierce SR, Estey EH (Oct 2006) The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations., British journal of haematology, 135 (2), 165-73
 - Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, Apperley J, Cervantes F, Cortes J, Deininger M, Gratwohl A, Guilhot F, Horowitz M, Hughes T, Kantarjian H, Larson R, Niederwieser D, Silver R, Hehlmann R (Sep 2006) Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet., Blood, 108 (6), 1809-20
 - Wilson CS, Davidson GS, Martin SB, Andries E, Potter J, Harvey R, Ar K, Xu Y, Kopecky KJ, Ankerst DP, Gundacker H, Slovak ML, Mosquera-Caro M, Chen IM, Stirewalt DL, Murphy M, Schultz FA, Kang H, Wang X, Radich JP, Appelbaum FR, Atlas SR, Godwin J, Willman CL (Jul 2006) Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction., Blood, 108 (2), 685-96
 - Slovak ML, Gundacker H, Bloomfield CD, Dewald G, Appelbaum FR, Larson RA, Tallman MS, Bennett JM, Stirewalt DL, Meshinchi S, Willman CL, Ravindranath Y, Alonzo TA, Carroll AJ, Raimondi SC, Heerema NA (Jul 2006) A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies., Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, 20 (7), 1295-7
 - Gopal AK, Pagel JM, Rajendran JG, Maloney DG, Appelbaum FR, Sorror ML, Sandmaier BM, Storb R, Press OW (Jul 2006) Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy., Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 12 (7), 697-702
 - Appelbaum FR, Gundacker H, Head DR, Slovak ML, Willman CL, Godwin JE, Anderson JE, Petersdorf SH (May 2006) Age and acute myeloid leukemia., Blood, 107 (9), 3481-5
 - Pagel JM, Appelbaum FR, Eary JF, Rajendran J, Fisher DR, Gooley T, Ruffner K, Nemecek E, Sickle E, Durack L, Carreras J, Horowitz MM, Press OW, Gopal AK, Martin PJ, Bernstein ID, Matthews DC (Mar 2006) 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission., Blood, 107 (5), 2184-91
 - Zaucha RE, Buckner DC, Barnett T, Holmberg LA, Gooley T, Hooper HA, Maloney DG, Appelbaum F, Bensinger WI (Jan 2006) Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies., International journal of radiation oncology, biology, physics, 64 (1), 227-34
 - O'Donnell MR, Appelbaum FR, Baer MR, Byrd JC, Coutre SE, Damon LE, Erba HP, Estey E, Foran J, Lancet J, Maness LJ, Maslak PG, Millenson M, Moore JO, Przepiorka D, Shami P, Smith BD, Stone RM, Tallman MS (Jan 2006) Acute myeloid leukemia clinical practice guidelines in oncology., Journal of the National Comprehensive Cancer Network : JNCCN, 4 (1), 16-36
 - Appelbaum FR, Pearce SF (2006) Hematopoietic cell transplantation in first complete remission versus early relapse., Best practice & research. Clinical haematology, 19 (2), 333-9
 - Walter RB, Pirga JL, Cronk MR, Mayer S, Appelbaum FR, Banker DE (Nov 2005) PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism., Blood, 106 (10), 3584-93
 - Hussein MA, Gundacker H, Head DR, Elias L, Foon KA, Boldt DH, Dobin SM, Dakhil SR, Budd GT, Appelbaum FR (Nov 2005) Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic
leukemia: a phase II SWOG TRIAL 9706., Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 19 (11), 1880-6
 - Larson RA, Sievers EL, Stadtmauer EA, Löwenberg B, Estey EH, Dombret H, Theobald M, Voliotis D, Bennett JM, Richie M, Leopold LH, Berger MS, Sherman ML, Loken MR, van Dongen JJ, Bernstein ID, Appelbaum FR (Oct 2005) Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence., Cancer, 104 (7), 1442-52
 - Kerbauy DM, Chyou F, Gooley T, Sorror ML, Scott B, Pagel JM, Myerson D, Appelbaum FR, Storb R, Deeg HJ (Sep 2005) Allogeneic hematopoietic cell transplantation for chronic myelomonocytic
leukemia., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (9), 713-20
 - Nash RA, Johnston L, Parker P, McCune JS, Storer B, Slattery JT, Furlong T, Anasetti C, Appelbaum FR, Lloid ME, Deeg HJ, Kiem HP, Martin PJ, Schubert MM, Witherspoon RP, Forman SJ, Blume KG, Storb R (Jul 2005) A phase I/II study of mycophenolate mofetil in combination with
cyclosporine for prophylaxis of acute graft-versus-host disease after
myeloablative conditioning and allogeneic hematopoietic cell
transplantation., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (7), 495-505
 - Carpenter PA, Lowder J, Johnston L, Frangoul H, Khoury H, Parker P, Jerome KR, McCune JS, Storer B, Martin P, Appelbaum F, Abonour R, Westervelt P, Anasetti C (Jun 2005) A phase II multicenter study of visilizumab, humanized anti-CD3 antibody,
to treat steroid-refractory acute graft-versus-host
disease., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (6), 465-71
 - Sanders JE, Im HJ, Hoffmeister PA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG, Bryant EM, Appelbaum FR (May 2005) Allogeneic hematopoietic cell transplantation for infants with acute
lymphoblastic leukemia., Blood, 105 (9), 3749-56
 - Wallen H, Gooley TA, Deeg HJ, Pagel JM, Press OW, Appelbaum FR, Storb R, Gopal AK (May 2005) Ablative allogeneic hematopoietic cell transplantation in adults 60 years
of age and older., Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 23 (15), 3439-46
 - Appelbaum FR, Dose intensity and the toxicity and efficacy of allogeneic hematopoietic
cell transplantation., Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 19(2), 171-5, Feb 2005
 - Oehler VG, Radich JP, Storer B, Blume KG, Chauncey T, Clift R, Snyder DS, Forman SJ, Flowers ME, Martin P, Guthrie KA, Negrin RS, Appelbaum FR, Bensinger W (Feb 2005) Randomized trial of allogeneic related bone marrow transplantation versus
peripheral blood stem cell transplantation for chronic myeloid
leukemia., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (2), 85-92
 - Sanders JE, Guthrie KA, Hoffmeister PA, Woolfrey AE, Carpenter PA, Appelbaum FR (Feb 2005) Final adult height of patients who received hematopoietic cell
transplantation in childhood., Blood, 105 (3), 1348-54
 - Flowers ME, Traina F, Storer B, Maris M, Bethge WA, Carpenter P, Appelbaum F, Storb R, Sandmaier BM, Martin PJ (Feb 2005) Serious graft-versus-host disease after hematopoietic cell transplantation
following nonmyeloablative conditioning., Bone Marrow Transplantation, 35 (3), 277-82
 - Appelbaum FR (Feb 2005) Innovations in preparative regimens for autologous hematopoietic cell
transplantation., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (2 Suppl 2), 40-2
 - Tse W, Joachim Deeg H, Stirewalt D, Appelbaum FR, Radich J, Gooley T (Jan 2005) Increased AF1q gene expression in high-risk myelodysplastic syndrome., British Journal of Haematology, 128 (2), 218-20
 - Byrd JC, Rai K, Peterson BL, Appelbaum FR, Morrison VA, Kolitz JE, Shepherd L, Hines JD, Schiffer CA, Larson RA (Jan 2005) Addition of rituximab to fludarabine may prolong progression-free survival
and overall survival in patients with previously untreated chronic
lymphocytic leukemia: an updated retrospective comparative analysis of
CALGB 9712 and CALGB 901, Blood, 105 (1), 49-53
 - Scott BL, Storer B, Loken MR, Storb R, Appelbaum FR, Deeg HJ (Jan 2005) Pretransplantation induction chemotherapy and posttransplantation relapse
in patients with advanced myelodysplastic syndrome., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (1), 65-73
 - Deeg HJ, Jiang PY, Holmberg LA, Scott B, Petersdorf EW, Appelbaum FR, Hematologic responses of patients with MDS to antithymocyte globulin plus
etanercept correlate with improved flow scores of marrow
cells, Leukemia Research, 28(11), 1177-80, Nov 2004
 - Banker DE, Mayer SJ, Li HY, Willman CL, Appelbaum FR, Zager RA, Cholesterol synthesis and import contribute to protective cholesterol
increments in acute myeloid leukemia cells, Blood, 104(6), 1816-24, Sep 2004
 - Martin PJ, Pei J, Gooley T, Anasetti C, Appelbaum FR, Deeg J, Hansen JA, Nash RA, Petersdorf EW, Storb R, Ghetie V, Schindler J, Vitetta ES, Evaluation of a CD25-specific immunotoxin for prevention of
graft-versus-host disease after unrelated marrow transplantation, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 10(8), 552-60, Aug 2004
 - Walter RB, Raden BW, Cronk MR, Bernstein ID, Appelbaum FR, Banker DE, The peripheral benzodiazepine receptor ligand PK11195 overcomes different
resistance mechanisms to sensitize AML cells to gemtuzumab
ozogamicin, Blood, 103(11), 4276-84, Jun 2004
 - Martin PJ, McDonald GB, Sanders JE, Anasetti C, Appelbaum FR, Deeg HJ, Nash RA, Petersdorf EW, Hansen JA, Storb R, Increasingly frequent diagnosis of acute gastrointestinal
graft-versus-host disease after allogeneic hematopoietic cell
transplantation, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 10(5), 320-7, May 2004
 - Yusuf U, Frangoul HA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG, Deeg HJ, Appelbaum FR, Anasetti C, Storb R, Sanders JE, Allogeneic bone marrow transplantation in children with myelodysplastic
syndrome or juvenile myelomonocytic leukemia: the Seattle
experience, Bone Marrow Transplantation, 33(8), 805-14, Apr 2004
 - Appelbaum FR, Use of granulocyte colony-stimulating factor following hematopoietic cell
transplantation: does haste make waste?, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 22(3), 390-1, Feb 2004
 - Appelbaum FR, Gundacker HM, Age and the nature of acute myeloid leukemia, Annals of Hematology, 83 Suppl 1, S106-7, 2004
 - Randolph SS, Gooley TA, Warren EH, Appelbaum FR, Riddell SR, Female donors contribute to a selective graft-versus-leukemia effect in
male recipients of HLA-matched, related hematopoietic stem cell
transplants, Blood, 103(1), 347-52, Jan 2004
 - Benesch M, McDonald GB, Schubert M, Appelbaum FR, Deeg HJ, Lack of cytoprotective effect of amifostine following HLA-identical
sibling transplantation for advanced myelodysplastic syndrome (MDS): a
pilot study, Bone Marrow Transplantation, 32(11), 1071-5, Dec 2003
 - Deeg HJ, Gooley TA, Flowers ME, Sale GE, Slattery JT, Anasetti C, Chauncey TR, Doney K, Georges GE, Kiem HP, Martin PJ, Petersdorf EW, Radich J, Sanders JE, Sandmaier BM, Warren EH, Witherspoon RP, Storb R, Appelbaum FR, Allogeneic hematopoietic stem cell transplantation for myelofibrosis, Blood, 102(12), 3912-8, Dec 2003
 - Maloney DG, Molina AJ, Sahebi F, Stockerl-Goldstein KE, Sandmaier BM, Bensinger W, Storer B, Hegenbart U, Somlo G, Chauncey T, Bruno B, Appelbaum FR, Blume KG, Forman SJ, McSweeney P, Storb R, Allografting with nonmyeloablative conditioning following cytoreductive
autografts for the treatment of patients with multiple
myeloma, Blood, 102(9), 3447-54, Nov 2003
 - Gopal AK, Gooley TA, Maloney DG, Petersdorf SH, Eary JF, Rajendran JG, Bush SA, Durack LD, Golden J, Martin PJ, Matthews DC, Appelbaum FR, Bernstein ID, Press OW, High-dose radioimmunotherapy versus conventional high-dose therapy and
autologous hematopoietic stem cell transplantation for relapsed follicular
non-Hodgkin lymphoma: a multivariable coho, Blood, 102(7), 2351-7, Oct 2003
 - Chen CS, Boeckh M, Seidel K, Clark JG, Kansu E, Madtes DK, Wagner JL, Witherspoon RP, Anasetti C, Appelbaum FR, Bensinger WI, Deeg HJ, Martin PJ, Sanders JE, Storb R, Storek J, Wade J, Siadak M, Flowers ME, Sullivan KM, Incidence, risk factors, and mortality from pneumonia developing late
after hematopoietic stem cell transplantation, Bone Marrow Transplantation, 32(5), 515-22, Sep 2003
 - Bornhauser M, Storer B, Slattery JT, Appelbaum FR, Deeg HJ, Hansen J, Martin PJ, McDonald GB, Nichols WG, Radich J, Woolfrey A, Jenke A, Schleyer E, Thiede C, Ehninger G, Anasetti C, Conditioning with fludarabine and targeted busulfan for transplantation of
allogeneic hematopoietic stem cells, Blood, 102(3), 820-6, Aug 2003
 - Doney K, Hagglund H, Leisenring W, Chauncey T, Appelbaum FR, Storb R, Predictive factors for outcome of allogeneic hematopoietic cell
transplantation for adult acute lymphoblastic leukemia, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 9(7), 472-81, Jul 2003
 - Radich JP, Gooley T, Bensinger W, Chauncey T, Clift R, Flowers M, Martin P, Slattery J, Sultan D, Appelbaum FR, HLA-matched related hematopoietic cell transplantation for chronic-phase
CML using a targeted busulfan and cyclophosphamide preparative
regimen, Blood, 102(1), 31-5, Jul 2003
 - Li HY, Appelbaum FR, Willman CL, Zager RA, Banker DE, Cholesterol-modulating agents kill acute myeloid leukemia cells and
sensitize them to therapeutics by blocking adaptive cholesterol
responses, Blood, 101(9), 3628-34, May 2003
 - Gallagher RE, Yeap BY, Bi W, Livak KJ, Beaubier N, Rao S, Bloomfield CD, Appelbaum FR, Tallman MS, Slack JL, Willman CL, Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute
promyelocytic leukemia: assessment of prognostic significance in adult
patients from intergroup protocol 0129, Blood, 101(7), 2521-8, Apr 2003
 - Appelbaum FR, New targets for therapy in acute myeloid leukemia, Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 17(3), 492-5, Mar 2003
 - Hsi ED, Kopecky KJ, Appelbaum FR, Boldt D, Frey T, Loftus M, Hussein MA, Prognostic significance of CD38 and CD20 expression as assessed by
quantitative flow cytometry in chronic lymphocytic
leukaemia, British Journal of Haematology, 120(6), 1017-25, Mar 2003
 - Stirewalt DL, Appelbaum FR, Willman CL, Zager RA, Banker DE, Mevastatin can increase toxicity in primary AMLs exposed to standard
therapeutic agents, but statin efficacy is not simply associated with ras
hotspot mutations or overexpression, Leukemia Research, 27(2), 133-45, Feb 2003
 - Appelbaum FR, The current status of hematopoietic cell transplantation, Annual Review of Medicine, 54, 491-512, 2003
 - Feinstein LC, Sandmaier BM, Hegenbart U, McSweeney PA, Maloney DG, Gooley TA, Maris MB, Chauncey TR, Bruno B, Appelbaum FR, Niederwieser DW, Storb RF, Non-myeloablative allografting from human leucocyte antigen-identical
sibling donors for treatment of acute myeloid leukaemia in first complete
remission, British Journal of Haematology, 120(2), 281-8, Jan 2003
 - Anderson JE, Kopecky KJ, Willman CL, Head D, O'Donnell MR, Luthardt FW, Norwood TH, Chen IM, Balcerzak SP, Johnson DB, Appelbaum FR, Outcome after induction chemotherapy for older patients with acute myeloid
leukemia is not improved with mitoxantrone and etoposide compared to
cytarabine and daunorubicin: a Southwest Onc, Blood, 100(12), 3869-76, Dec 2002
 - Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Woods WG, Ogden A, Weinstein H, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH, All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome
and prognostic factor analysis from the North American Intergroup
protocol, Blood, 100(13), 4298-302, Dec 2002
 - List AF, Kopecky KJ, Willman CL, Head DR, Slovak ML, Douer D, Dakhil SR, Appelbaum FR, Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia
blast phase, Blood, 100(5), 1910-2, Sep 2002
 - Morrison VA, Rai KR, Peterson BL, Kolitz JE, Elias L, Appelbaum FR, Hines JD, Shepherd L, Larson RA, Schiffer CA, Therapy-related myeloid leukemias are observed in patients with chronic
lymphocytic leukemia after treatment with fludarabine and chlorambucil:
results of an intergroup study, cancer and l, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 20(18), 3878-84, Sep 2002
 - Larson RA, Boogaerts M, Estey E, Karanes C, Stadtmauer EA, Sievers EL, Mineur P, Bennett JM, Berger MS, Eten CB, Munteanu M, Loken MR, Van Dongen JJ, Bernstein ID, Appelbaum FR, Mylotarg Study Group, Antibody-targeted chemotherapy of older patients with acute myeloid
leukemia in first relapse using Mylotarg (gemtuzumab
ozogamicin), Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 16(9), 1627-36, Sep 2002
 - McCune JS, Gooley T, Gibbs JP, Sanders JE, Petersdorf EW, Appelbaum FR, Anasetti C, Risler L, Sultan D, Slattery JT, Busulfan concentration and graft rejection in pediatric patients
undergoing hematopoietic stem cell transplantation, Bone Marrow Transplantation, 30(3), 167-73, Aug 2002
 - Deeg HJ, Storer B, Slattery JT, Anasetti C, Doney KC, Hansen JA, Kiem HP, Martin PJ, Petersdorf E, Radich JP, Sanders JE, Shulman HM, Warren EH, Witherspoon RP, Bryant EM, Chauncey TR, Getzendaner L, Storb R, Appelbaum FR, Conditioning with targeted busulfan and cyclophosphamide for hemopoietic
stem cell transplantation from related and unrelated donors in patients
with myelodysplastic syndrome, Blood, 100(4), 1201-7, Aug 2002
 - Wolman SR, Gundacker H, Appelbaum FR, Slovak ML, Southwest Oncology Group, Impact of trisomy 8 (+8) on clinical presentation, treatment response, and
survival in acute myeloid leukemia: a Southwest Oncology Group
study, Blood, 100(1), 29-35, Jul 2002
 - Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI, Storb R, Appelbaum FR, Forman SJ, Blume KG, Martin PJ, Comparison of chronic graft-versus-host disease after transplantation of
peripheral blood stem cells versus bone marrow in allogeneic recipients:
long-term follow-up of a randomized trial, Blood, 100(2), 415-9, Jul 2002
 - Koc S, Leisenring W, Flowers ME, Anasetti C, Deeg HJ, Nash RA, Sanders JE, Witherspoon RP, Storb R, Appelbaum FR, Martin PJ, Therapy for chronic graft-versus-host disease: a randomized trial
comparing cyclosporine plus prednisone versus prednisone
alone, Blood, 100(1), 48-51, Jul 2002
 - Platzbecker U, Gooley T, Anasetti C, Appelbaum FR, Clurman B, Doney K, Chauncey T, Flowers ME, Myerson D, Radich JP, Storb R, Witherspoon RP, Deeg HJ, Curative therapy of advanced essential thrombocythemia or polycythemia
vera by hemopoietic stem cell transplantation, Leukemia & Lymphoma, 43(7), 1409-14, Jul 2002
 - Doney KC, Chauncey T, Appelbaum FR, Seattle Bone Marrow Transplant Team, Allogeneic related donor hematopoietic stem cell transplantation for
treatment of chronic lymphocytic leukemia, Bone Marrow Transplantation, 29(10), 817-23, May 2002
 - Pagel JM, Matthews DC, Appelbaum FR, Bernstein ID, Press OW, The use of radioimmunoconjugates in stem cell transplantation, Bone Marrow Transplantation, 29(10), 807-16, May 2002
 - Gopal AK, Rajendran JG, Petersdorf SH, Maloney DG, Eary JF, Wood BL, Gooley TA, Bush SA, Durack LD, Martin PJ, Matthews DC, Appelbaum FR, Bernstein ID, Press OW, High-dose chemo-radioimmunotherapy with autologous stem cell support for
relapsed mantle cell lymphoma, Blood, 99(9), 3158-62, May 2002
 - Appelbaum FR, Hematopoietic cell transplantation as a form of immunotherapy, International Journal of Hematology, 75(3), 222-7, Apr 2002
 - Appelbaum FR, Sandmaier B, Sensitivity of renal cell cancer to nonmyeloablative allogeneic
hematopoietic cell transplantations: unusual or unusually
important?, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 20(8), 1965-7, Apr 2002
 - Carpenter PA, Appelbaum FR, Corey L, Deeg HJ, Doney K, Gooley T, Krueger J, Martin P, Pavlovic S, Sanders J, Slattery J, Levitt D, Storb R, Woolfrey A, Anasetti C, A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment
of steroid-refractory acute graft-versus-host disease, Blood, 99(8), 2712-9, Apr 2002
 - Woolfrey AE, Anasetti C, Storer B, Doney K, Milner LA, Sievers EL, Carpenter P, Martin P, Petersdorf E, Appelbaum FR, Hansen JA, Sanders JE, Factors associated with outcome after unrelated marrow transplantation for
treatment of acute lymphoblastic leukemia in children, Blood, 99(6), 2002-8, Mar 2002
 - Appelbaum FR, Hematopoietic cell transplantation beyond first remission, Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 16(2), 157-9, Feb 2002
 - Banker DE, Cooper JJ, Fennell DA, Willman CL, Appelbaum FR, Cotter FE, PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes
acute myeloid leukemia cells to relevant therapeutic agents by more than
one mechanism, Leukemia Research, 26(1), 91-106, Jan 2002
 - Hoelzer D, Gokbuget N, Ottmann O, Pui CH, Relling MV, Appelbaum FR, van Dongen JJ, Szczepanski T, Acute lymphoblastic leukemia, Hematology / the Education Program of the American Society of Hematology American Society of Hematology. Education Program., 162-92, 2002
 - Furlong T, Leisenring W, Storb R, Anasetti C, Appelbaum FR, Carpenter PA, Deeg HJ, Doney K, Kiem HP, Nash RA, Sanders JE, Witherspoon R, Thompson D, Martin PJ, Psoralen and ultraviolet A irradiation (PUVA) as therapy for
steroid-resistant cutaneous acute graft-versus-host
disease, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 8(4), 206-12, 2002
 - Kansu E, Gooley T, Flowers ME, Anasetti C, Deeg HJ, Nash RA, Sanders JE, Witherspoon RP, Appelbaum FR, Storb R, Martin PJ, Administration of cyclosporine for 24 months compared with 6 months for
prevention of chronic graft-versus-host disease: a prospective randomized
clinical trial, Blood, 98(13), 3868-70, Dec 2001
 - Benito AI, Furlong T, Martin PJ, Anasetti C, Appelbaum FR, Doney K, Nash RA, Papayannopoulou T, Storb R, Sullivan KM, Witherspoon R, Deeg HJ, Sirolimus (rapamycin) for the treatment of steroid-refractory acute
graft-versus-host disease, Transplantation, 72(12), 1924-9, Dec 2001
 - List AF, Kopecky KJ, Willman CL, Head DR, Persons DL, Slovak ML, Dorr R, Karanes C, Hynes HE, Doroshow JH, Shurafa M, Appelbaum FR, Benefit of cyclosporine modulation of drug resistance in patients with
poor-risk acute myeloid leukemia: a Southwest Oncology Group
study, Blood, 98(12), 3212-20, Dec 2001
 - Storek J, Joseph A, Espino G, Dawson MA, Douek DC, Sullivan KM, Flowers ME, Martin P, Mathioudakis G, Nash RA, Storb R, Appelbaum FR, Maloney DG, Immunity of patients surviving 20 to 30 years after allogeneic or
syngeneic bone marrow transplantation, Blood, 98(13), 3505-12, Dec 2001
 - Gutierrez-Delgado F, Maloney DG, Press OW, Golden J, Holmberg LA, Maziarz RT, Hooper H, Buckner CD, Appelbaum FR, Bensinger WI, Autologous stem cell transplantation for non-Hodgkin's lymphoma:
comparison of radiation-based and chemotherapy-only preparative
regimens, Bone Marrow Transplantation, 28(5), 455-61, Sep 2001
 - Radich JP, Gooley T, Bryant E, Chauncey T, Clift R, Beppu L, Edmands S, Flowers ME, Kerkof K, Nelson R, Appelbaum FR, The significance of bcr-abl molecular detection in chronic myeloid
leukemia patients "late," 18 months or more after transplantation, Blood, 98(6), 1701-7, Sep 2001
 - Linenberger ML, Hong T, Flowers D, Sievers EL, Gooley TA, Bennett JM, Berger MS, Leopold LH, Appelbaum FR, Bernstein ID, Multidrug-resistance phenotype and clinical responses to gemtuzumab
ozogamicin, Blood, 98(4), 988-94, Aug 2001
 - Morrison VA, Rai KR, Peterson BL, Kolitz JE, Elias L, Appelbaum FR, Hines JD, Shepherd L, Martell RE, Larson RA, Schiffer CA, Impact of therapy With chlorambucil, fludarabine, or fludarabine plus
chlorambucil on infections in patients with chronic lymphocytic leukemia:
Intergroup Study Cancer and Leukemia Group B, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 19(16), 3611-21, Aug 2001
 - Anderson JE, Tefferi A, Craig F, Holmberg L, Chauncey T, Appelbaum FR, Guardiola P, Callander N, Freytes C, Gazitt Y, Razvillas B, Deeg HJ, Myeloablation and autologous peripheral blood stem cell rescue results in
hematologic and clinical responses in patients with myeloid metaplasia
with myelofibrosis, Blood, 98(3), 586-93, Aug 2001
 - Appelbaum FR, Perspectives on the future of chronic myeloid leukemia treatment, Seminars in Hematology, 38(3 Suppl 8), 35-42, Jul 2001
 - Sievers EL, Larson RA, Stadtmauer EA, Estey E, Lowenberg B, Dombret H, Karanes C, Theobald M, Bennett JM, Sherman ML, Berger MS, Eten CB, Loken MR, van Dongen JJ, Bernstein ID, Appelbaum FR, Mylotarg Study Group, Efficacy and safety of gemtuzumab ozogamicin in patients with
CD33-positive acute myeloid leukemia in first relapse, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 19(13), 3244-54, Jul 2001
 - Stirewalt DL, Kopecky KJ, Meshinchi S, Appelbaum FR, Slovak ML, Willman CL, Radich JP, FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid
leukemia, Blood, 97(11), 3589-95, Jun 2001
 - Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA, Witherspoon RP, Bensinger W, Flowers ME, Martin P, Storb R, Appelbaum FR, Boeckh M, Immune reconstitution after allogeneic marrow transplantation compared
with blood stem cell transplantation, Blood, 97(11), 3380-9, Jun 2001
 - McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, Chauncey TR, Gooley TA, Hegenbart U, Nash RA, Radich J, Wagner JL, Minor S, Appelbaum FR, Bensinger WI, Bryant E, Flowers ME, Georges GE, Grumet FC, Kiem HP, Torok-Storb B, Yu, Hematopoietic cell transplantation in older patients with hematologic
malignancies: replacing high-dose cytotoxic therapy with
graft-versus-tumor effects, Blood, 97(11), 3390-400, Jun 2001
 - Appelbaum FR, Haematopoietic cell transplantation as immunotherapy, Nature, 411(6835), 385-9, May 2001
 - Rowley SD, Donaldson G, Lilleby K, Bensinger WI, Appelbaum FR, Experiences of donors enrolled in a randomized study of allogeneic bone
marrow or peripheral blood stem cell transplantation, Blood, 97(9), 2541-8, May 2001
 - Al-Ghamdi H, Leisenring W, Bensinger WI, Nash RA, Storb R, Appelbaum FR, Martin PJ, A proposed objective way to assess results of randomized prospective
clinical trials with acute graft-versus-host disease as an outcome of
interest, British Journal of Haematology, 113(2), 461-9, May 2001
 - Appelbaum FR, Who should be transplanted for AML?, Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 15(4), 680-2, Apr 2001
 - Garrido SM, Appelbaum FR, Willman CL, Banker DE, Acute myeloid leukemia cells are protected from spontaneous and
drug-induced apoptosis by direct contact with a human bone marrow stromal
cell line (HS-5), Experimental Hematology, 29(4), 448-57, Apr 2001
 - Witherspoon RP, Deeg HJ, Storer B, Anasetti C, Storb R, Appelbaum FR, Hematopoietic stem-cell transplantation for treatment-related leukemia or
myelodysplasia, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 19(8), 2134-41, Apr 2001
 - Deeg HJ, Appelbaum FR, Stem-cell transplantation for myelofibrosis, The New England Journal of Medicine, 344(10), 775-6, Mar 2001
 - Gopal AK, Gooley TA, Golden JB, Maloney DG, Bensinger WI, Petersdorf SH, Appelbaum FR, Press OW, Efficacy of high-dose therapy and autologous hematopoietic stem cell
transplantation for non-Hodgkin's lymphoma in adults 60 years of age and
older, Bone Marrow Transplantation, 27(6), 593-9, Mar 2001
 - Petersdorf SH, Kopecky KJ, Head DR, Boldt DH, Balcerzak SP, Wun T, Roy V, Veith RW, Appelbaum FR, Comparison of the L10M consolidation regimen to an alternative regimen
including escalating methotrexate/L-asparaginase for adult acute
lymphoblastic leukemia: a Southwest Oncology Group
, Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 15(2), 208-16, Feb 2001
 - Appelbaum FR, Rowe JM, Radich J, Dick JE, Acute myeloid leukemia, Hematology / the Education Program of the American Society of Hematology American Society of Hematology. Education Program., 62-86, 2001
 - Garrido SM, Cooper JJ, Appelbaum FR, Willman CL, Kopecky K, Banker DE, Blasts from elderly acute myeloid leukemia patients are characterized by
low levels of culture- and drug-induced apoptosis, Leukemia Research, 25(1), 23-32, Jan 2001
 - Bennett CL, Hynes D, Godwin J, Stinson TJ, Golub RM, Appelbaum FR, Southwest Oncology Group, Economic analysis of granulocyte colony stimulating factor as adjunct
therapy for older patients with acute myelogenous leukemia (AML):
estimates from a Southwest Oncology Group clinical
, Cancer Investigation, 19(6), 603-10, 2001
 - Anderson JE, Appelbaum FR, Schoch G, Barnett T, Chauncey TR, Flowers ME, Storb R, Relapse after allogeneic bone marrow transplantation for refractory anemia
is increased by shielding lungs and liver during total body
irradiation, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 7(3), 163-70, 2001
 - Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, Kashyap A, Flowers ME, Lilleby K, Chauncey TR, Storb R, Appelbaum FR, Transplantation of bone marrow as compared with peripheral-blood cells
from HLA-identical relatives in patients with hematologic
cancers, The New England Journal of Medicine, 344(3), 175-81, Jan 2001
 - Storb R, Blume KG, O'Donnell MR, Chauncey T, Forman SJ, Deeg HJ, Hu WW, Appelbaum FR, Doney K, Flowers ME, Sanders J, Leisenring W, Cyclophosphamide and antithymocyte globulin to condition patients with
aplastic anemia for allogeneic marrow transplantations: the experience in
four centers, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 7(1), 39-44, 2001
 - Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD, Schiffer CA, Fludarabine compared with chlorambucil as primary therapy for chronic
lymphocytic leukemia, The New England Journal of Medicine, 343(24), 1750-7, Dec 2000
 - Koc S, Leisenring W, Flowers ME, Anasetti C, Deeg HJ, Nash RA, Sanders JE, Witherspoon RP, Appelbaum FR, Storb R, Martin PJ, Thalidomide for treatment of patients with chronic graft-versus-host
disease, Blood, 96(12), 3995-6, Dec 2000
 - Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, Paietta E, Willman CL, Head DR, Rowe JM, Forman SJ, Appelbaum FR, Karyotypic analysis predicts outcome of preremission and postremission
therapy in adult acute myeloid leukemia: a Southwest Oncology
Group/Eastern Cooperative Oncology Group Study, Blood, 96(13), 4075-83, Dec 2000
 - Furlong T, Storb R, Anasetti C, Appelbaum FR, Deeg HJ, Doney K, Martin P, Sullivan K, Witherspoon R, Nash RA, Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute
graft-versus-host disease resistant to cyclosporine or for
cyclosporine-associated toxicities, Bone Marrow Transplantation, 26(9), 985-91, Nov 2000
 - Appelbaum FR, Baer MR, Carabasi MH, Coutre SE, Erba HP, Estey E, Glenn MJ, Kraut EH, Maslak P, Millenson M, Miller CB, Saba HI, Stone R, Tallman MS, National Comprehensive Cancer Network, NCCN Practice Guidelines for Acute Myelogenous Leukemia, Oncology (williston Park, N.y.), 14(11A), 53-61, Nov 2000
 - Press OW, Eary JF, Gooley T, Gopal AK, Liu S, Rajendran JG, Maloney DG, Petersdorf S, Bush SA, Durack LD, Martin PJ, Fisher DR, Wood B, Borrow JW, Porter B, Smith JP, Matthews DC, Appelbaum FR, Bernstein ID, A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide,
cyclophosphamide, and autologous stem cell transplantation for relapsed
B-cell lymphomas, Blood, 96(9), 2934-42, Nov 2000
 - Koc S, Hagglund H, Ireton RC, Perez-Simon JA, Collins SJ, Appelbaum FR, Successful treatment of severe hemorrhagic cystitis with cystectomy
following matched donor allogeneic hematopoietic cell
transplantation, Bone Marrow Transplantation, 26(8), 899-901, Oct 2000
 - Deeg HJ, Appelbaum FR, Hematopoietic stem cell transplantation in patients with myelodysplastic
syndrome, Leukemia Research, 24(8), 653-63, Aug 2000
 - Deeg HJ, Flowers ME, Leisenring W, Appelbaum FR, Martin PJ, Storb RF, Cyclosporine (CSP)or CSP plus methylprednisolone for graft-versus-host
disease prophylaxis in patients with high-risk lymphohemopoietic
malignancies: long-term follow-up of a randomized tr, Blood, 96(3), 1194-5, Aug 2000
 - Sierra J, Storer B, Hansen JA, Martin PJ, Petersdorf EW, Woolfrey A, Matthews D, Sanders JE, Storb R, Appelbaum FR, Anasetti C, Unrelated donor marrow transplantation for acute myeloid leukemia: an
update of the Seattle experience, Bone Marrow Transplantation, 26(4), 397-404, Aug 2000
 - Zhang FF, Murata-Collins JL, Gaytan P, Forman SJ, Kopecky KJ, Willman CL, Appelbaum FR, Slovak ML, Twenty-four-color spectral karyotyping reveals chromosome aberrations in
cytogenetically normal acute myeloid leukemia, Genes, Chromosomes & Cancer, 28(3), 318-28, Jul 2000
 - Gutierrez-Delgado F, Holmberg LA, Hooper H, Appelbaum FR, Livingston RB, Maziarz RT, Weiden P, Rivkin S, Montgomery P, Kawahara K, Bensinger W, High-dose busulfan, melphalan and thiotepa as consolidation for
non-inflammatory high-risk breast cancer, Bone Marrow Transplantation, 26(1), 51-9, Jul 2000
 - Chauncey TR, Rankin C, Anderson JE, Chen I, Kopecky KJ, Godwin JE, Kalaycio ME, Moore DF, Shurafa MS, Petersdorf SH, Kraut EH, Leith CP, Head DR, Luthardt FW, Willman CL, Appelbaum FR, A phase I study of induction chemotherapy for older patients with newly
diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and
the MDR modulator PSC 833: a southwest onc, Leukemia Research, 24(7), 567-74, Jul 2000
 - Garrido SM, Bryant E, Appelbaum FR, Allogeneic stem cell transplantation for relapsed and refractory acute
myeloid leukemia patients with 11q23 abnormalities, Leukemia Research, 24(6), 481-6, Jun 2000
 - Crump C, Chen C, Appelbaum FR, Kopecky KJ, Schwartz SM, Willman CL, Slovak ML, Weiss NS, Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid
leukemia, Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 9(5), 457-60, May 2000
 - Garrido SM, Willman C, Appelbaum FR, Banker DE, Three-color versus four-color multiparameter cell cycle analyses of
primary acute myeloid leukemia samples, Cytometry : the Journal of the Society for Analytical Cytology, 42(2), 83-94, Apr 2000
 - Appelbaum FR, Is there a best transplant conditioning regimen for acute myeloid
leukemia?, Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 14(3), 497-501, Mar 2000
 - Deeg HJ, Appelbaum FR, Hemopoietic stem cell transplantation for myelodysplastic syndrome, Current Opinion in Oncology, 12(2), 116-20, Mar 2000
 - Rosen PJ, Rankin C, Head DR, Boldt DH, Luthardt FW, Norwood T, Pugh RP, Karanes C, Appelbaum FR, A phase II study of high dose ARA-C and mitoxantrone for treatment of
relapsed or refractory adult acute lymphoblastic leukemia, Leukemia Research, 24(3), 183-7, Mar 2000
 - Deeg HJ, Shulman HM, Anderson JE, Bryant EM, Gooley TA, Slattery JT, Anasetti C, Fefer A, Storb R, Appelbaum FR, Allogeneic and syngeneic marrow transplantation for myelodysplastic
syndrome in patients 55 to 66 years of age, Blood, 95(4), 1188-94, Feb 2000
 - Radich JP, Gooley T, Sanders JE, Anasetti C, Chauncey T, Appelbaum FR, Second allogeneic transplantation after failure of first autologous
transplantation, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 6(3), 272-9, 2000
 - Cavallaro AM, Lilleby K, Majolino I, Storb R, Appelbaum FR, Rowley SD, Bensinger WI, Three to six year follow-up of normal donors who received recombinant
human granulocyte colony-stimulating factor, Bone Marrow Transplantation, 25(1), 85-9, Jan 2000
 - Nash RA, Kurzrock R, DiPersio J, Vose J, Linker C, Maharaj D, Nademanee AP, Negrin R, Nimer S, Shulman H, Ashby M, Jones D, Appelbaum FR, Champlin R, A phase I trial of recombinant human thrombopoietin in patients with
delayed platelet recovery after hematopoietic stem cell
transplantation, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 6(1), 25-34, 2000
 - Flowers ME, Leisenring W, Beach K, Riddell S, Radich JP, Higano CS, Rowley SD, Chauncey TR, Sanders JE, Anasetti C, Storb R, Wade J, Appelbaum FR, Martin P, Granulocyte colony-stimulating factor given to donors before apheresis
does not prevent aplasia in patients treated with donor leukocyte infusion
for recurrent chronic myeloid leukemia aft, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 6(3A), 321-6, 2000
 - Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Rowe JM, Francois C, Larson RS, Wiernik PH, Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome., Blood, 95(1), 90-5, 1 2000
 - Holmberg LA, Boeckh M, Hooper H, Leisenring W, Rowley S, Heimfeld S, Press O, Maloney DG, McSweeney P, Corey L, Maziarz RT, Appelbaum FR, Bensinger W, Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation., Blood, 94(12), 4029-35, 15 Dec 1999
 - Clift RA, Radich J, Appelbaum FR, Martin P, Flowers ME, Deeg HJ, Storb R, Thomas ED, Long-term follow-up of a randomized study comparing cyclophosphamide and
total body irradiation with busulfan and cyclophosphamide for patients
receiving allogenic marrow transplants durin, Blood, 94(11), 3960-2, Dec 1999
 - Appelbaum FR, Antibody-targeted therapy for myeloid leukemia, Seminars in Hematology, 36(4 Suppl 6), 2-8, October 1999
 - Appelbaum FR, Molecular diagnosis and clinical decisions in adult acute leukemia, Seminars in Hematology, 36(4), 401-10, Oct 1999
 - Martin PJ, Rowley SD, Anasetti C, Chauncey TR, Gooley T, Petersdorf EW, van Burik JA, Flowers ME, Storb R, Appelbaum FR, Hansen JA, A phase I-II clinical trial to evaluate removal of CD4 cells and partial
depletion of CD8 cells from donor marrow for HLA-mismatched unrelated
recipients, Blood, 94(7), 2192-9, Oct 1999
 - Silver RT, Woolf SH, Hehlmann R, Appelbaum FR, Anderson J, Bennett C, Goldman JM, Guilhot F, Kantarjian HM, Lichtin AE, Talpaz M, Tura S, An evidence-based analysis of the effect of busulfan, hydroxyurea,
interferon, and allogeneic bone marrow transplantation in treating the
chronic phase of chronic myeloid leukemia: develop, Blood, 94(5), 1517-36, Sep 1999
 - Karanes C, Kopecky KJ, Head DR, Grever MR, Hynes HE, Kraut EH, Vial RH, Lichtin A, Nand S, Samlowski WE, Appelbaum FR, A phase III comparison of high dose ARA-C \(HIDAC\) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group Study., Leukemia Research, 23(9), 787-94, September 1999
 - Matthews DC, Appelbaum FR, Eary JF, Fisher DR, Durack LD, Hui TE, Martin PJ, Mitchell D, Press OW, Storb R, Bernstein ID, Phase I study of \(131\)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome., Blood, 94(4), 1237-47, 15 Aug 1999
 - Leith CP, Kopecky KJ, Chen IM, Eijdems L, Slovak ML, McConnell TS, Head DR, Weick J, Grever MR, Appelbaum FR, Willman CL, Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study., Blood, 94(3), 1086-99, 1 Aug 1999
 - Appelbaum FR, Choosing the source of stem cells for allogeneic transplantation: no
longer a peripheral issue, Blood, 94(2), 381-3, July 1999
 - Stirewalt DL, Clurman B, Appelbaum FR, Willman CL, Radich JP, p73 mutations and expression in adult de novo acute myelogenous leukemia., Leukemia, 13(7), 985-90, July 1999
 - Gibbs JP, Gooley T, Corneau B, Murray G, Stewart P, Appelbaum FR, Slattery JT, The impact of obesity and disease on busulfan oral clearance in adults., Blood, 93(12), 4436-40, 15 Jun 1999
 - Sievers EL, Appelbaum FR, Spielberger RT, Forman SJ, Flowers D, Smith FO, Shannon-Dorcy K, Berger MS, Bernstein ID, Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate., Blood, 93(11), 3678-84, 1 Jun 1999
 - Li Q, Kopecky KJ, Mohan A, Willman CL, Appelbaum FR, Weick JK, Issa JP, Estrogen receptor methylation is associated with improved survival in
adult acute myeloid leukemia, Clinical Cancer Research : an Official Journal of the American Association for Cancer Research., 5(5), 1077-84, May 1999
 - Matthews DC, Martin PJ, Nourigat C, Appelbaum FR, Fisher DR, Bernstein ID, Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models., Blood, 93(2), 737-45, 15 Jan 1999
 - Storb R, Raff RF, Graham T, Appelbaum FR, Deeg HJ, Schuening FG, Sale G, Seidel K, Dose rate-dependent marrow toxicity of TBI in dogs and marrow sparing effect at high dose rate by dose fractionation., Biology of Blood and Marrow Transplantation, 5(3), 155-61, 1999
 - D.R, Weick, J, Grever, M.R, Appelbaum, F.R, and Willman, C.L. Leith, C.P, Kopecky, K.J, Chen, I-M, Eijdems, L, Slovak, M.L, McConnell, T.S., Head, Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia patients less than 70 years old. A Sout, Blood, 94, 1086-1099, 1999
- Banker DE, Radich J, Becker A, Kerkof K, Norwood T, Willman C, Appelbaum FR, The t(8;21) translocation is not consistently associated with high Bcl-2
expression in de novo acute myeloid leukemias of adults, Clinical Cancer Research : an Official Journal of the American Association for Cancer Research., 4(12), 3051-62, Dec 1998
 - Cassileth PA, Harrington DP, Appelbaum FR, Lazarus HM, Rowe JM, Paietta E, Willman C, Hurd DD, Bennett JM, Blume KG, Head DR, Wiernik PH, Chemotherapy compared with autologous or allogeneic bone marrow
transplantation in the management of acute myeloid leukemia in first
remission, The New England Journal of Medicine, 339(23), 1649-56, Dec 1998
 - Woolfrey AE, Gooley TA, Sievers EL, Milner LA, Andrews RG, Walters M, Hoffmeister P, Hansen JA, Anasetti C, Bryant E, Appelbaum FR, Sanders JE, Bone marrow transplantation for children less than 2 years of age with
acute myelogenous leukemia or myelodysplastic syndrome, Blood, 92(10), 3546-56, Nov 1998
 - Liu SY, Eary JF, Petersdorf SH, Martin PJ, Maloney DG, Appelbaum FR, Matthews DC, Bush SA, Durack LD, Fisher DR, Gooley TA, Bernstein ID, Press OW, Follow-up of relapsed B-cell lymphoma patients treated with
iodine-131-labeled anti-CD20 antibody and autologous stem-cell
rescue, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 16(10), 3270-8, Oct 1998
 - Holmberg LA, Demirer T, Rowley S, Buckner CD, Goodman G, Maziarz R, Klarnet J, Zuckerman N, Harrer G, McCloskey R, Gersh R, Goldberg R, Nichols W, Jacobs A, Weiden P, Montgomery P, Rivkin S, Appelbaum FR, Bensinger WI, High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell \(PBSC\) rescue in patients with advanced stage III/IV ovarian cancer., Bone Marrow Transplantation, 22(7), 651-9, October 1998
 - Ren S, Kalhorn T F, McDonald G B, Anasetti C, Appelbaum F R, Slattery J T, Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients., Clinical Pharmacology and Therapeutics, 64(3), 289-301, September 1998
 - Appelbaum FR, Anderson J, Allogeneic bone marrow transplantation for myelodysplastic syndrome:
outcomes analysis according to IPSS score, Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 12 Suppl 1, S25-9, Sep 1998
 - Clift R A, Buckner C D, Appelbaum F R, Sullivan K M, Storb R, Thomas E D, Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia [letter], Blood, 92(4), 1455-6, 15 Aug 1998
 - Morton A J, Gooley T, Hansen J A, Appelbaum F R, Bruemmer B, Bjerke J W, Clift R, Martin P J, Petersdorf E W, Sanders J E, Storb R, Sullivan K M, Woolfrey A, Anasetti C, Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase., Blood, 92(2), 394-401, 15 Jul 1998
 - Sullivan K M, Anasetti C, Horowitz M, Rowlings P A, Petersdorf E W, Martin P J, Clift R A, Walters M C, Gooley T, Sierra J, Anderson J E, Bjerke J, Siadak M, Flowers M E, Nash R A, Sanders J E, Appelbaum F R, Storb R, Hansen J A, Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant, Annals of The New York Academy of Sciences, 850, 312-24, 30 Jun 1998
 - Godwin J E, Kopecky K J, Head D R, Willman C L, Leith C P, Hynes H E, Balcerzak S P, Appelbaum F R, A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031)., Blood, 91(10), 3607-15, 15 May 1998
 - Appelbaum F R, Anderson J, Bone marrow transplantation for myelodysplasia in adults and children: when and who?, Leukemia Research, 22 Suppl 1, S35-9, May 1998
 - Sandmaier B M, Storb R, Bennett K L, Appelbaum F R, Santos E B, Epitope specificity of CD44 for monoclonal antibody-dependent facilitation of marrow engraftment in a canine model., Blood, 91(9), 3494-502, 1 May 1998
 - Storb R, Raff R, Deeg H J, Graham T, Appelbaum F R, Schuening F G, Shulman H, Seidel K, Leisenring W, Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autografts., International Journal of Radiation Oncology, Biology, Physics, 40(4), 961-6, 1 Mar 1998
 - Banker D E, Groudine M, Willman C L, Norwood T, Appelbaum F R, Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents., Leukemia Research, 22(3), 221-39, March 1998
 - Sullivan KM, Kansu E, Storer B, Jocom J, Emerson G, Reagan T, Emerson V, Siadak MF, Davis C, Appelbaum FR, Buckner CD, Hansen JA, Shulman HM, Storb R, McDonald GB, Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease
after bone marrow transplantation, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 4(1), 20-6, 1998
 - Banker, D.E, Groudine, M, Willman, C.L, Norwood, T, Appelbaum, F.R., Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents, Leukemia Research, 22, 221-239, 1998
- Banker, D.E, Radich, J, Becker, A, Kerkof, K, Norwood, T, Willman, C, Appelbaum, F.R., The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults, Clinical Cancer Research, 4, 3051-3062, 1998
- Storek J, Gooley T, Siadak M, Bensinger W I, Maloney D G, Chauncey T R, Flowers M, Sullivan K M, Witherspoon R P, Rowley S D, Hansen J A, Storb R, Appelbaum F R, Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease., Blood, 90(12), 4705-9, 15 Dec 1997
 - Appelbaum F R, Kopecky K J, Long-term survival after chemotherapy for acute myeloid leukemia: the experience of the Southwest Oncology Group., Cancer, 80(11 Suppl), 2199-204, 1 Dec 1997
 - Chen C S, Seidel K, Armitage J O, Fay J W, Appelbaum F R, Horowitz M M, Shpall E J, Weiden P L, Antman K S, Champlin R E, Kersey J H, Sullivan K M, Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation., Biology of Blood and Marrow Transplantation, 3(6), 331-40, December 1997
 - Schuening F G, von Kalle C, Kiem H P, Appelbaum F R, Deeg H J, Pepe M, Gooley T, Graham T C, Hackman R C, Storb R, Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs., Experimental Hematology, 25(12), 1240-5, November 1997
 - Schiffman K, Buckner C D, Maziarz R, Maloney D G, Appelbaum F R, Press O, Gooley T, Holmberg L, Lilleby K, Clift R, Zuckerman N, Klarnet J, Weaver C, Chauncey T, Bensinger W I, High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease., Biology of Blood and Marrow Transplantation, 3(5), 261-6, November 1997
 - Tallman M S, Andersen J W, Schiffer C A, Appelbaum F R, Feusner J H, Ogden A, Shepherd L, Willman C, Bloomfield C D, Rowe J M, Wiernik P H, All-trans-retinoic acid in acute promyelocytic leukemia [see comments], New England Journal of Medicine, 337(15), 1021-8, 9 Oct 1997
 - Storb R, Leisenring W, Anasetti C, Appelbaum F R, Deeg H J, Doney K, Martin P, Sullivan K M, Witherspoon R, Pettinger M, Bensinger W, Buckner C D, Clift R, Flowers M E, Hansen J A, Pepe M, Chauncey T, Sanders J, Thomas E D, Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?, Biology of Blood and Marrow Transplantation, 3(4), 194-201, October 1997
 - Anderson J E, Sale G, Appelbaum F R, Chauncey T R, Storb R, Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis., British Journal of Haematology, 98(4), 1010-6, September 1997
 - Gallagher R E, Willman C L, Slack J L, Andersen J W, Li Y P, Viswanatha D, Bloomfield C D, Appelbaum F R, Schiffer C A, Tallman M S, Wiernik P H, Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study., Blood, 90(4), 1656-63, 15 Aug 1997
 - Sierra J, Radich J, Hansen J A, Martin P J, Petersdorf E W, Bjerke J, Bryant E, Nash R A, Sanders J E, Storb R, Sullivan K M, Appelbaum F R, Anasetti C, Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia., Blood, 90(4), 1410-4, 15 Aug 1997
 - Anderson J E, Appelbaum F R, Myelodysplasia and myeloproliferative disorders., Current Opinion In Hematology, 4(4), 261-7, July 1997
 - Bensinger W I, Schiffman K S, Holmberg L, Appelbaum F R, Maziarz R, Montgomery P, Ellis E, Rivkin S, Weiden P, Lilleby K, Rowley S, Petersdorf S, Klarnet J P, Nichols W, Hertler A, McCroskey R, Weaver C H, Buckner C D, High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer., Bone Marrow Transplantation, 19(12), 1183-9, June 1997
 - Sierra J, Storer B, Hansen J A, Bjerke J W, Martin P J, Petersdorf E W, Appelbaum F R, Bryant E, Chauncey T R, Sale G, Sanders J E, Storb R, Sullivan K M, Anasetti C, Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose., Blood, 89(11), 4226-35, 1 Jun 1997
 - Storb R, Leisenring W, Anasetti C, Appelbaum F R, Buckner C D, Bensinger W I, Chauncey T, Clift R A, Deeg H J, Doney K C, Flowers M E, Hansen J A, Martin P J, Sanders J E, Sullivan K M, Witherspoon R P, Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin [letter], Blood, 89(10), 3890-1, 15 May 1997
 - Deeg H J, Lin D, Leisenring W, Boeckh M, Anasetti C, Appelbaum F R, Chauncey T R, Doney K, Flowers M, Martin P, Nash R, Schoch G, Sullivan K M, Witherspoon R P, Storb R, Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial., Blood, 89(10), 3880-7, 15 May 1997
 - Appelbaum F R, Allogeneic stem cell transplantation for the treatment of hematologic malignancies: current indications and challenges., Journal of rheumatology. Supplement, 48, 41-5, May 1997
 - Appelbaum F R, Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL)., Leukemia, 11 Suppl 4, S15-7, May 1997
 - Leith C P, Kopecky K J, Godwin J, McConnell T, Slovak M L, Chen I M, Head D R, Appelbaum F R, Willman C L, Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southw, Blood, 89(9), 3323-9, 1 May 1997
 - Slattery J T, Clift R A, Buckner C D, Radich J, Storer B, Bensinger W I, Soll E, Anasetti C, Bowden R, Bryant E, Chauncey T, Deeg H J, Doney K C, Flowers M, Gooley T, Hansen J A, Martin P J, McDonald G B, Nash R, Petersdorf E W, Sanders J E, Schoch G, Stewart P, Storb R, Appelba, Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation., Blood, 89(8), 3055-60, 15 Apr 1997
 - Radich J, Gehly G, Lee A, Avery R, Bryant E, Edmands S, Gooley T, Kessler P, Kirk J, Ladne P, Thomas E D, Appelbaum F R, Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation., Blood, 89(7), 2602-9, 1 Apr 1997
 - Anderson J E, Gooley T A, Schoch G, Anasetti C, Bensinger W I, Clift R A, Hansen J A, Sanders J E, Storb R, Appelbaum F R, Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy., Blood, 89(7), 2578-85, 1 Apr 1997
 - Robinson N, Benyunes M C, Thompson J A, York A, Petersdorf S, Press O, Lindgren C, Chauncey T, Buckner C D, Bensinger W I, Appelbaum F R, Fefer A, Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study., Bone Marrow Transplantation, 19(5), 435-42, March 1997
 - Demirer T, Buckner C D, Storer B, Lilleby K, Rowley S, Clift R, Appelbaum F R, Storb R, Bensinger W I, Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor., Journal of Clinical Oncology, 15(2), 684-90, February 1997
 - Appelbaum F R, Allogeneic hematopoietic stem cell transplantation for acute leukemia., Seminars In Oncology, 24(1), 114-23, February 1997
 - Doney K, Leisenring W, Storb R, Appelbaum F R, Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team [see comments], Annals of Internal Medicine, 126(2), 107-15, 15 Jan 1997
 - Matthews D C, Appelbaum F R, Press O W, Eary J F, Bernstein I D, The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignancies., Cancer Treatment and Research, 77, 121-39, 1997
 - Banker D E, Groudine M, Norwood T, Appelbaum F R, Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia., Blood, 89(1), 243-55, 1 Jan 1997
 - Banker, D.E, Groudine, M, Norwood, T, Appelbaum, F.R., Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia, Blood, 89, 243-255, 1997
- Tsai T, Davalath S, Rankin C, Radich J P, Head D, Appelbaum F R, Boldt D H, Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory, Leukemia, 10(12), 1901-10, December 1996
 - Bensinger W I, Buckner C D, Shannon-Dorcy K, Rowley S, Appelbaum F R, Benyunes M, Clift R, Martin P, Demirer T, Storb R, Lee M, Schiller G, Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy., Blood, 88(11), 4132-8, 1 Dec 1996
 - Corcoran M C, Press O W, Matthews D C, Appelbaum F R, Bernstein I D, The role of radioimmunotherapy in bone marrow transplantation., Current Opinion In Hematology, 3(6), 438-45, November 1996
 - Weick J K, Kopecky K J, Appelbaum F R, Head D R, Kingsbury L L, Balcerzak S P, Bickers J N, Hynes H E, Welborn J L, Simon S R, Grever M, A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study., Blood, 88(8), 2841-51, 15 Oct 1996
 - Huss R, Deeg H J, Gooley T, Bryant E, Leisenring W, Clift R, Buckner C D, Martin P, Storb R, Appelbaum F R, Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia., Bone Marrow Transplantation, 18(4), 767-76, October 1996
 - Bensinger W I, Clift R, Martin P, Appelbaum F R, Demirer T, Gooley T, Lilleby K, Rowley S, Sanders J, Storb R, Buckner C D, Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation., Blood, 88(7), 2794-800, 1 Oct 1996
 - Bensinger W I, Buckner C D, Anasetti C, Clift R, Storb R, Barnett T, Chauncey T, Shulman H, Appelbaum F R, Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome., Blood, 88(7), 2787-93, 1 Oct 1996
 - McSweeney P A, Rouleau K A, Storb R, Bolles L, Wallace P M, Beauchamp M, Krizanac-Bengez L, Moore P, Sale G, Sandmaier B, de Revel T, Appelbaum F R, Nash R A, Canine CD34: cloning of the cDNA and evaluation of an antiserum to recombinant protein., Blood, 88(6), 1992-2003, 15 Sep 1996
 - Bensinger W I, Demirer T, Buckner C D, Appelbaum F R, Storb R, Lilleby K, Weiden P, Bluming A Z, Fefer A, Syngeneic marrow transplantation in patients with multiple myeloma., Bone Marrow Transplantation, 18(3), 527-31, September 1996
 - Kiem H P, Leisenring W, Raff R, Deeg H J, Schuening F G, Appelbaum F R, Storb R, Failure of recombinant stem cell factor to enhance engraftment of L-leucyl-L-leucine methyl ester treated canine marrow after irradiation [letter], Blood, 88(5), 1896-7, 1 Sep 1996
 - Martin P J, Nelson B J, Appelbaum F R, Anasetti C, Deeg H J, Hansen J A, McDonald G B, Nash R A, Sullivan K M, Witherspoon R P, Scannon P J, Friedmann N, Storb R, Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation., Blood, 88(3), 824-30, 1 Aug 1996
 - Brunvand M W, Bensinger W I, Soll E, Weaver C H, Rowley S D, Appelbaum F R, Lilleby K, Clift R A, Gooley T A, Press O W, Fefer A, Storb R, Sanders J E, Martin P L, Chauncey T, Maziarz R T, Zuckerman N, Montgomery P, Dorn R, Weiden P L, Demirer T, Holmberg L A, Schiffman K, McSw, High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells., Bone Marrow Transplantation, 18(1), 131-41, July 1996
 - Demirer T, Petersen F B, Bensinger W I, Appelbaum F R, Fefer A, Rowley S, Sanders J, Chauncey T, Storb R, Lilleby K, Buckner C D, Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia., Bone Marrow Transplantation, 18(1), 29-34, July 1996
 - Schiffman K S, Bensinger W I, Appelbaum F R, Rowley S, Lilleby K, Clift R A, Weaver C H, Demirer T, Sanders J E, Petersdorf S, Gooley T, Weiden P, Zuckerman N, Montgomery P, Maziarz R, Klarnet J P, Rivkin S, Trueblood K, Storb R, Holmberg L, Buckner C D, Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease., Bone Marrow Transplantation, 17(6), 943-50, June 1996
 - Demirer T, Buckner C D, Gooley T, Appelbaum F R, Rowley S, Chauncey T, Lilleby K, Storb R, Bensinger W I, Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma., Bone Marrow Transplantation, 17(6), 937-41, June 1996
 - Kiem H P, McDonald G B, Myerson D, Spurgeon C L, Deeg H J, Sanders J E, Doney K, Appelbaum F R, Sullivan K M, Witherspoon R P, Storb R, Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors., Biology of Blood and Marrow Transplantation, 2(2), 93-9, May 1996
 - Walters M C, Patience M, Leisenring W, Eckman J R, Buchanan G R, Rogers Z R, Olivieri N E, Vichinsky E, Davies S C, Mentzer W C, Powars D, Scott J P, Bernaudin F, Ohene-Frempong K, Darbyshire P J, Wayne A, Roberts I A, Dinndorf P, Brandalise S, Sanders J E, Matthews D C, Appe, Barriers to bone marrow transplantation for sickle cell anemia., Biology of Blood and Marrow Transplantation, 2(2), 100-4, May 1996
 - Demirer T, Buckner C D, Appelbaum F R, Clift R, Storb R, Myerson D, Lilleby K, Rowley S, Bensinger W I, High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer., Bone Marrow Transplantation, 17(5), 769-74, May 1996
 - Appelbaum F R, The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer [see comments], Ca: A Cancer Journal for Clinicians, 46(3), 142-64, May 1996
 - Doney K, Storb R, Lilleby K, Appelbaum F R, Recombinant interleukin-1 followed by immunosuppressive therapy for aplastic anemia [letter], American Journal of Hematology, 52(1), 61-2, May 1996
 - Slattery J T, Kalhorn T F, McDonald G B, Lambert K, Buckner C D, Bensinger W I, Anasetti C, Appelbaum F R, Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients., Journal of Clinical Oncology, 14(5), 1484-94, May 1996
 - Bensinger W I, Rowley S D, Demirer T, Lilleby K, Schiffman K, Clift R A, Appelbaum F R, Fefer A, Barnett T, Storb R, Chauncey T, Maziarz R T, Klarnet J, McSweeney P, Holmberg L, Maloney D G, Weaver C H, Buckner C D, High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma., Journal of Clinical Oncology, 14(5), 1447-56, May 1996
 - Press O W, Shan D, Howell-Clark J, Eary J, Appelbaum F R, Matthews D, King D J, Haines A M, Hamann P, Hinman L, Shochat D, Bernstein I D, Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells., Cancer Research, 56(9), 2123-9, 1 May 1996
 - Demirer T, Buckner C D, Appelbaum F R, Bensinger W I, Sanders J, Lambert K, Clift R, Fefer A, Storb R, Slattery J T, Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan ba, Bone Marrow Transplantation, 17(4), 491-5, April 1996
 - Sanders J E, Hawley J, Levy W, Gooley T, Buckner C D, Deeg H J, Doney K, Storb R, Sullivan K, Witherspoon R, Appelbaum F R, Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation., Blood, 87(7), 3045-52, 1 Apr 1996
 - Anderson J E, Anasetti C, Appelbaum F R, Schoch G, Gooley T A, Hansen J A, Buckner C D, Sanders J E, Sullivan K M, Storb R, Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia., British Journal of Haematology, 93(1), 59-67, April 1996
 - Bensinger W I, Buckner C D, Rowley S, Storb R, Appelbaum F R, Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells., Bone Marrow Transplantation, 17 Suppl 2, S19-21, March 1996
 - Demirer T, Buckner C D, Appelbaum F R, Lambert K, Bensinger W I, Clift R, Storb R, Slattery J T, Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based o, Bone Marrow Transplantation, 17(3), 341-6, March 1996
 - Robinson N, Sanders J E, Benyunes M C, Beach K, Lindgren C, Thompson J A, Appelbaum F R, Fefer A, Phase I trial of interleukin-2 after unmodified HLA-matched sibling bone marrow transplantation for children with acute leukemia., Blood, 87(4), 1249-54, 15 Feb 1996
 - Sullivan K M, Storek J, Kopecky K J, Jocom J, Longton G, Flowers M, Siadak M, Nims J, Witherspoon R P, Anasetti C, Appelbaum F R, Bowden R A, Buckner C D, Crawford S W, Deeg H J, Hansen J A, McDonald G B, Sanders J E, Storb R, A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on s, Biology of Blood and Marrow Transplantation, 2(1), 44-53, February 1996
 - Appelbaum F R, Progress in adult acute lymphoblastic leukemia [editorial], Western Journal of Medicine, 164(2), 180-1, February 1996
 - Vose J M, Anderson J E, Bierman P J, Appelbaum F R, Anderson J R, Garrison L, Lebsack M E, Armitage J O, Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancy., Journal of Clinical Oncology, 14(2), 520-6, February 1996
 - Bean M A, Graham T, Appelbaum F R, Deeg H J, Schuening F, Sale G E, Leisenring W, Pepe M, Storb R, Gamma radiation of blood products prevents rejection of subsequent DLA-identical marrow grafts. Tolerance versus abrogation of sensitization to non-DLA antigens., Transplantation, 61(2), 334-5, 27 Jan 1996
 - Nash RA, Gooley T, Davis C, Appelbaum FR, The problem of thrombocytopenia after hematopoietic stem cell
transplantation, Stem Cells (dayton, Ohio), 14 Suppl 1, 261-73, 1996
 - Anderson J E, Appelbaum F R, Schoch G, Gooley T, Anasetti C, Bensinger W I, Bryant E, Buckner C D, Chauncey T, Clift R A, et al, Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic f, Journal of Clinical Oncology, 14(1), 220-6, January 1996
 - Anderson J E, Appelbaum F R, Schoch G, Gooley T, Anasetti C, Bensinger W I, Bryant E, Buckner C D, Chauncey T R, Clift R A, Doney K, Flowers M, Hansen J A, Martin P J, Matthews D C, Sanders J E, Shulman H, Sullivan K M, Witherspoon R P, Storb R, Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors., Blood, 87(1), 51-8, 1 Jan 1996
 - Soll E, Massumoto C, Clift R A, Buckner C D, Appelbaum F R, Storb R, Sale G, Hackman R, Martin P, Relevance of marrow fibrosis in bone marrow transplantation: a retrospective analysis of engraftment., Blood, 86(12), 4667-73, 15 Dec 1995
 - Appelbaum F, Fay J, Herzig G, Kersey J, Parkman R, Petersdorf E, Przepiorka D, Saral R, Shpall E, Wolf J, American Society for Blood and Marrow Transplantation guidelines for training., Biology of Blood and Marrow Transplantation, 1(1), 56, November 1995
 - Balduzzi A, Gooley T, Anasetti C, Sanders J E, Martin P J, Petersdorf E W, Appelbaum F R, Buckner C D, Matthews D, Storb R, et al, Unrelated donor marrow transplantation in children., Blood, 86(8), 3247-56, 15 Oct 1995
 - Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, et al, Factors that influence collection and engraftment of autologous peripheral-blood stem cells., Journal of Clinical Oncology, 13(10), 2547-55, October 1995
 - Leith C P, Chen I M, Kopecky K J, Appelbaum F R, Head D R, Godwin J E, Weick J K, Willman C L, Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and, Blood, 86(6), 2329-42, 15 Sep 1995
 - Meyskens F L Jr, Kopecky K J, Appelbaum F R, Balcerzak S P, Samlowski W, Hynes H, Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial., Leukemia Research, 19(9), 605-12, September 1995
 - Kalhs P, Schwarzinger I, Anderson G, Mori M, Clift R A, Storb R, Buckner C D, Appelbaum F R, Hansen J A, Sullivan K M, A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leu, Blood, 86(5), 2028-32, 1 Sep 1995
 - Nash R A, Burstein S A, Storb R, Yang W, Abrams K, Appelbaum F R, Boone T, Deeg H J, Durack L D, Schuening F G, Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets., Blood, 86(5), 1765-75, 1 Sep 1995
 - Press O W, Eary J F, Appelbaum F R, Martin P J, Nelp W B, Glenn S, Fisher D R, Porter B, Matthews D C, Gooley T, et al, Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas., Lancet, 346(8971), 336-40, 5 Aug 1995
 - Appelbaum F R, Clift R, Radich J, Anasetti C, Buckner C D, Bone marrow transplantation for chronic myelogenous leukemia., Seminars In Oncology, 22(4), 405-11, August 1995
 - Demirer T, Petersen F B, Appelbaum F R, Barnett T A, Sanders J, Deeg H J, Storb R, Doney K, Bensinger W I, Shannon-Dorcy K, et al, Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial., International Journal of Radiation Oncology, Biology, Physics, 32(4), 1103-9, 15 Jul 1995
 - Matthews D C, Appelbaum F R, Press O W, Eary J F, Bernstein I D, Targeted therapy for hematologic malignancies: has its promise been realized? [editorial], Current Opinion In Hematology, 2(4), 235-9, July 1995
 - Welborn J L, Kopecky K J, Meyers F J, Veith R, Shurafa M, Doroshow J H, Balcerzak S P, Appelbaum F R, Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial., Leukemia, 9(7), 1126-9, July 1995
 - Slattery J T, Sanders J E, Buckner C D, Schaffer R L, Lambert K W, Langer F P, Anasetti C, Bensinger W I, Fisher L D, Appelbaum F R, et al, Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics [published erratum appears in Bone Marrow Transplant 1996 Oct;18(4):829], Bone Marrow Transplantation, 16(1), 31-42, July 1995
 - Appelbaum F R, Allogeneic marrow transplantation and the use of hematopoietic growth factors., Stem Cells, 13(4), 344-50, July 1995
 - Demirer T, Rowley S, Buckner C D, Appelbaum F R, Lilleby K, Storb R, Schiffman K, Bensinger W I, Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer., Journal of Clinical Oncology, 13(7), 1714-9, July 1995
 - Nash R A, Etzioni R, Storb R, Furlong T, Gooley T, Anasetti C, Appelbaum F R, Doney K, Martin P, Slattery J, et al, Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a singl, Blood, 85(12), 3746-53, 15 Jun 1995
 - Slovak M L, Kopecky K J, Wolman S R, Henslee-Downey J P, Appelbaum F R, Forman S J, Blume K G, Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: a Southwest Oncology Group study (SWOG-8612)., Leukemia Research, 19(6), 381-8, June 1995
 - Slovak M L, Traweek S T, Willman C L, Head D R, Kopecky K J, Magenis R E, Appelbaum F R, Forman S J, Trisomy 11: an association with stem/progenitor cell immunophenotype., British Journal of Haematology, 90(2), 266-73, June 1995
 - Demirer T, Buckner C D, Appelbaum F R, Petersen F B, Rowley S, Weaver C H, Lilleby K, Sanders J, Chauncey T, Storb R, et al, Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leuke, Bone Marrow Transplantation, 15(6), 915-22, June 1995
 - Demirer T, Gooley T, Buckner C D, Petersen F B, Lilleby K, Rowley S, Sanders J, Storb R, Appelbaum F R, Bensinger W I, Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation., Bone Marrow Transplantation, 15(6), 907-13, June 1995
 - Nash R A, Seidel K, Storb R, Slichter S, Schuening F G, Appelbaum F R, Becker A B, Bolles L, Deeg H J, Graham T, et al, Effects of rhIL-11 on normal dogs and after sublethal radiation., Experimental Hematology, 23(5), 389-96, May 1995
 - Bigelow C L, Kopecky K, Files J C, Head D, Lipschitz D A, Grever M, Appelbaum F R, Treatment of acute myelogenous leukemia in patients over 50 years of age with V-TAD: a Southwest Oncology Group study., American Journal of Hematology, 48(4), 228-32, April 1995
 - Bensinger W I, Weaver C H, Appelbaum F R, Rowley S, Demirer T, Sanders J, Storb R, Buckner C D, Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor [see comments], Blood, 85(6), 1655-8, 15 Mar 1995
 - Deeg H J, Seidel K, Bruemmer B, Pepe M S, Appelbaum F R, Impact of patient weight on non-relapse mortality after marrow transplantation., Bone Marrow Transplantation, 15(3), 461-8, March 1995
 - Anderson J E, Appelbaum F R, Storb R, An update on allogeneic marrow transplantation for myelodysplastic syndrome., Leukemia and Lymphoma, 17(1-2), 95-9, March 1995
 - Matthews D C, Appelbaum F R, Eary J F, Fisher D R, Durack L D, Bush S A, Hui T E, Martin P J, Mitchell D, Press O W, et al, Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irrad, Blood, 85(4), 1122-31, 15 Feb 1995
 - Langenmayer I, Weaver C, Buckner C D, Lilleby K, Appelbaum F R, Longin K, Rowley S, Storb R, Singer J, Bensinger W I, Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both., Bone Marrow Transplantation, 15(2), 241-6, February 1995
 - Press O W, Eary J F, Appelbaum F R, Bernstein I D, Myeloablative radiolabeled antibody therapy with autologous bone marrow transplantation for relapsed B cell lymphomas., Cancer Treatment and Research, 76, 281-97, 1995
 - Andrews R G, Briddell R A, Knitter G H, Rowley S D, Appelbaum F R, McNiece I K, Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates., Blood, 85(1), 15-20, 1 Jan 1995
 - Press O W, Appelbaum F R, Eary J F, Bernstein I D, Radiolabeled antibody therapy of lymphomas., Important Advances In Oncology, 157-71, 1995
 - Lynch M H, Petersen F B, Appelbaum F R, Bensinger W I, Clift R A, Storb R, Sanders J E, Hansen J A, Buckner C D, Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies., Bone Marrow Transplantation, 15(1), 59-64, January 1995
 - Press OW, Appelbaum FR, Eary JF, Bernstein ID, Radiolabeled antibody therapy of lymphomas., Important Advances in Oncology, 157-71, 1995
 - Weaver C H, Clift R A, Deeg H J, Storb R, Appelbaum F R, Bensinger W, Doney K, Hansen J A, Martin P O, Sanders J, et al, Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia., Bone Marrow Transplantation, 14(6), 885-93, December 1994
 - Schuening F, Miller A D, Torok-Storb B, Bensinger W, Storb R, Reynolds T, Fisher L, Buckner C D, Appelbaum F R, Study on contribution of genetically marked peripheral blood repopulating cells to hematopoietic reconstitution after transplantation., Human Gene Therapy, 5(12), 1523-34, December 1994
 - Boldt D H, Kopecky K J, Head D, Gehly G, Radich J P, Appelbaum F R, Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience., Leukemia, 8(12), 2118-26, December 1994
 - Weaver C H, Petersen F B, Appelbaum F R, Bensinger W I, Press O, Martin P, Sandmaier B, Deeg H J, Hansen J A, Brunvand M, et al, High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma., Journal of Clinical Oncology, 12(12), 2559-66, December 1994
 - Storb R, Raff R F, Appelbaum F R, Deeg H J, Graham T C, Schuening F G, Shulman H, Yu C, Bryant E, Burnett R, et al, DLA-identical bone marrow grafts after low-dose total body irradiation: the effect of canine recombinant hematopoietic growth factors., Blood, 84(10), 3558-66, 15 Nov 1994
 - Weaver C H, Bensinger W I, Appelbaum F R, Lilleby K, Sandmaier B, Brunvand M, Rowley S, Petersdorf S, Rivkin S, Gooley T, et al, Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies., Bone Marrow Transplantation, 14(5), 813-9, November 1994
 - Silberman G, Crosse M G, Peterson E A, Weston R C, Horowitz M M, Appelbaum F R, Cheson B D, Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries [see comments], New England Journal of Medicine, 331(16), 1063-7, 20 Oct 1994
 - Nemunaitis J, Ross M, Meisenberg B, O'Reilly R, Lilleby K, Buckner C D, Appelbaum F R, Buhles W, Singer J, Peters W P, Phase I study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failure., Bone Marrow Transplantation, 14(4), 583-8, October 1994
 - Anasetti C, Hansen J A, Waldmann T A, Appelbaum F R, Davis J, Deeg H J, Doney K, Martin P J, Nash R, Storb R, et al, Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor., Blood, 84(4), 1320-7, 15 Aug 1994
 - Andrews R G, Briddell R A, Knitter G H, Opie T, Bronsden M, Myerson D, Appelbaum F R, McNiece I K, In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells., Blood, 84(3), 800-10, 1 Aug 1994
 - Storb R, Etzioni R, Anasetti C, Appelbaum F R, Buckner C D, Bensinger W, Bryant E, Clift R, Deeg H J, Doney K, et al, Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia., Blood, 84(3), 941-9, 1 Aug 1994
 - Demirer T, Buckner C D, Lilleby K, Weaver C, Longin K, Appelbaum F R, Bensinger W I, Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed disease., Cancer, 74(2), 715-21, 15 Jul 1994
 - Scott A A, Head D R, Kopecky K J, Appelbaum F R, Theil K S, Grever M R, Chen I M, Whittaker M H, Griffith B B, Licht J D, et al, HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3, Blood, 84(1), 244-55, 1 Jul 1994
 - Eary J F, Pollard K R, Durack L D, Bice A N, Lewellen T K, Matthews D, Press O W, Nelp W B, Appelbaum F R, Bernstein I, Post therapy imaging in high dose I-131 radioimmunotherapy patients., Medical Physics, 21(7), 1157-62, July 1994
 - Luce BR, Singer JW, Weschler JM, Buckner CD, Sheingold SH, Shannon-Dorcy K, Appelbaum FR, Nemunaitis J, Recombinant human granulocyte-macrophage colony-stimulating factor after
autologous bone marrow transplantation for lymphoid cancer: an economic
analysis of a randomised, double-blind, pla, Pharmacoeconomics, 6(1), 42-8, Jul 1994
 - de Revel T, Appelbaum F R, Storb R, Schuening F, Nash R, Deeg J, McNiece I, Andrews R, Graham T, Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs., Blood, 83(12), 3795-9, 15 Jun 1994
 - Nemunaitis J, Appelbaum F R, Lilleby K, Buhles W C, Rosenfeld C, Zeigler Z R, Shadduck R K, Singer J W, Meyer W, Buckner C D, Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia., Blood, 83(12), 3473-9, 15 Jun 1994
 - Deeg H J, Anasetti C, Petersdorf E, Storb R, Doney K, Hansen J A, Sanders J, Sullivan K M, Appelbaum F R, Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated, Blood, 83(11), 3417-8, 1 Jun 1994
 - Storb R, Raff R F, Appelbaum F R, Deeg H J, Graham T C, Schuening F G, Sale G, Bryant E, Seidel K, Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts., Blood, 83(11), 3384-9, 1 Jun 1994
 - Busca A, Anasetti C, Anderson G, Appelbaum F R, Buckner C D, Doney K, Martin P J, Petersdorf E, Sanders J E, Hansen J A, Unrelated donor or autologous marrow transplantation for treatment of acute leukemia., Blood, 83(10), 3077-84, 15 May 1994
 - Anderson JE, Appelbaum FR, Hematopoietic effects and clinical uses of granulocyte-macrophage
colony-stimulating factor and PIXY321, Current Opinion in Hematology, 1(3), 203-9, May 1994
 - Andrews RG, Briddell RA, Appelbaum FR, McNiece IK, Stimulation of hematopoiesis in vivo by stem cell factor., Curr Opin Hematol, 1(3), 187-96, May 1994
 - Deeg H J, Beckham C, Huss R, Myerson D, Greinix H, Appelbaum F R, Graham T, Schuening F, Storb R, Rescue from anti-MHC class II antibody-mediated marrow graft failure by c-kit ligand., Blood, 83(8), 2352-9, 15 Apr 1994
 - Nash R A, Schuening F G, Seidel K, Appelbaum F R, Boone T, Deeg H J, Graham T C, Hackman R, Sullivan-Pepe M, Storb R, Effect of recombinant canine granulocyte-macrophage colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation., Blood, 83(7), 1963-70, 1 Apr 1994
 - Kiem H P, Darovsky B, von Kalle C, Goehle S, Stewart D, Graham T, Hackman R, Appelbaum F R, Deeg H J, Miller A D, et al, Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells., Blood, 83(6), 1467-73, 15 Mar 1994
 - Saez R, Dahlberg S, Appelbaum F R, Hartsock R J, Lemaistre F, Coltman C A Jr, Fisher R I, Autologous bone marrow transplantation in adults with non-Hodgkin's lymphoma: a Southwest Oncology Group study., Hematological Oncology, 12(2), 75-85, March 1994
 - Schwarzinger I, Raff R F, Flowers M, Niederwieser D, Graham T, Shulman H, Appelbaum F R, Schuening F, Storb R, Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow., Bone Marrow Transplantation, 13(3), 303-9, March 1994
 - Bean M A, Graham T, Appelbaum F R, Deeg H J, Schuening F, Sale G E, Storb R, Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts., Transplantation, 57(3), 423-6, February 1994
 - Schuening F G, Nemunaitis J, Appelbaum F R, Storb R, Hematopoietic growth factors after allogeneic marrow transplantation in animal studies and clinical trials., Bone Marrow Transplantation, 14 Suppl 4, S74-7, 1994
 - Head D R, Kopecky K J, Willman C, Appelbaum F R, Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience., Leukemia, 8 Suppl 2, S38-41, 1994
 - Bearman S I, Mori M, Beatty P G, Meyer W G, Buckner C D, Petersen F B, Sanders J E, Anasetti C, Martin P, Appelbaum F R, et al, Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors., Bone Marrow Transplantation, 13(1), 31-5, January 1994
 - Anderson J E, Litzow M R, Appelbaum F R, Schoch G, Fisher L D, Buckner C D, Petersen F B, Crawford S W, Press O W, Sanders J E, et al, Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience., Journal of Clinical Oncology, 11(12), 2342-50, December 1993
 - Appelbaum F R, The use of colony stimulating factors in marrow transplantation., Cancer, 72(11 Suppl), 3387-92, 1 Dec 1993
 - Nemunaitis J, Appelbaum F R, Singer J W, Lilleby K, Wolff S, Greer J P, Bierman P, Resta D, Campion M, Levitt D, et al, Phase I trial with recombinant human interleukin-3 in patients with lymphoma undergoing autologous bone marrow transplantation., Blood, 82(11), 3273-8, 1 Dec 1993
 - Collins C, Eary J F, Donaldson G, Vernon C, Bush N E, Petersdorf S, Livingston R B, Gordon E E, Chapman C R, Appelbaum F R, Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial., Journal of Nuclear Medicine, 34(11), 1839-44, November 1993
 - Press O W, Eary J F, Appelbaum F R, Martin P J, Badger C C, Nelp W B, Glenn S, Butchko G, Fisher D, Porter B, et al, Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support [see comments], New England Journal of Medicine, 329(17), 1219-24, 21 Oct 1993
 - Doney K, Buckner C D, Fisher L, Petersen F B, Sanders J, Appelbaum F R, Anasetti C, Badger C, Bensinger W, Deeg H J, et al, Autologous bone marrow transplantation for acute lymphoblastic leukemia., Bone Marrow Transplantation, 12(4), 315-21, October 1993
 - Clift R A, Bianco J A, Appelbaum F R, Buckner C D, Singer J W, Bakke L, Bensinger W I, Bowden R A, McDonald G B, Schubert M, et al, A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation., Blood, 82(7), 2025-30, 1 Oct 1993
 - Clift R A, Appelbaum F R, Thomas E D, Treatment of chronic myeloid leukemia by marrow transplantation [editorial; comment] [see comments], Blood, 82(7), 1954-6, 1 Oct 1993
 - Weaver C H, Buckner C D, Longin K, Appelbaum F R, Rowley S, Lilleby K, Miser J, Storb R, Hansen J A, Bensinger W, Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor., Blood, 82(7), 1981-4, 1 Oct 1993
 - Storb R, Raff R F, Appelbaum F R, Deeg H J, Fitzsimmons W, Graham T C, Pepe M, Pettinger M, Sale G, van der Jagt R, et al, FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors., Transplantation, 56(4), 800-7, October 1993
 - Doney K, Storb R, Appelbaum F R, Buckner C D, Sanders J, Singer J, Hansen J A, Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemia., British Journal of Haematology, 85(1), 182-4, September 1993
 - Nemunaitis J, Shannon-Dorcy K, Appelbaum F R, Meyers J, Owens A, Day R, Ando D, O'Neill C, Buckner D, Singer J, Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor., Blood, 82(5), 1422-7, 1 Sep 1993
 - Appelbaum F R, The influence of total dose, fractionation, dose rate, and distribution of total body irradiation on bone marrow transplantation., Seminars In Oncology, 20(4 Suppl 4), 3-10; quiz 11, August 1993
 - Anderson J E, Appelbaum F R, Fisher L D, Schoch G, Shulman H, Anasetti C, Bensinger W I, Bryant E, Buckner C D, Doney K, et al, Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome., Blood, 82(2), 677-81, 15 Jul 1993
 - Appelbaum F R, Indications for bone marrow transplantation (BMT) in the treatment of acute myeloid leukemia (AML)., Leukemia, 7(7), 1081, July 1993
 - Petersen F B, Lynch M H, Clift R A, Appelbaum F R, Sanders J E, Bensinger W I, Benyunes M C, Doney K, Fefer A, Martin P, et al, Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission., Journal of Clinical Oncology, 11(7), 1353-60, July 1993
 - Weaver C H, Appelbaum F R, Petersen F B, Clift R, Singer J, Press O, Bensinger W, Bianco J, Martin P, Anasetti C, et al, High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy., Journal of Clinical Oncology, 11(7), 1329-35, July 1993
 - Raff R F, Severns E M, Storb R, Graham T C, Sale G, Schuening F G, Appelbaum F R, Studies of the use of L-leucyl-L-leucine methyl ester in canine allogeneic marrow transplantation., Transplantation, 55(6), 1244-9, June 1993
 - Storb R, Raff R F, Graham T, Appelbaum F R, Deeg H J, Schuening F G, Shulman H, Pepe M, Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine model [see comments], International Journal of Radiation Oncology, Biology, Physics, 26(2), 275-83, 20 May 1993
 - Blume K G, Kopecky K J, Henslee-Downey J P, Forman S J, Stiff P J, LeMaistre C F, Appelbaum F R, A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not, Blood, 81(8), 2187-93, 15 Apr 1993
 - Bensinger W I, Price T H, Dale D C, Appelbaum F R, Clift R, Lilleby K, Williams B, Storb R, Thomas E D, Buckner C D, The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis [see comments], Blood, 81(7), 1883-8, 1 Apr 1993
 - Schiffman K, Clift R, Appelbaum F R, Sanders J, Bensinger W, Petersen F B, Rowley S, Hill R, Martin P, Storb R, et al, Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia., Bone Marrow Transplantation, 11(3), 227-32, March 1993
 - Pene R, Appelbaum F R, Fisher L, Lilleby K, Nemunaitis J, Storb R, Buckner C D, Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation., Bone Marrow Transplantation, 11(3), 219-22, March 1993
 - Raff R F, Storb R, Graham T, Deeg H J, Pepe M, Schaffer R, Sale G E, Schuening F, Appelbaum F R, What role for 15-deoxyspergualin in enhancing engraftment of unrelated, histoincompatible canine marrow grafts and preventing graft-versus-host disease?, Transplantation, 55(3), 684-8, March 1993
 - Elias L, Stock-Novack D, Head D R, Grever M R, Weick J K, Chapman R A, Godwin J E, Metz E N, Appelbaum F R, A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study., Leukemia, 7(3), 361-5, March 1993
 - Nemunaitis J, Anasetti C, Buckner C D, Appelbaum F R, Shannon-Dorcy K, Hansen J, Singer J W, Long-term follow-up of 103 patients who received recombinant human granulocyte-macrophage colony-stimulating factor after unrelated donor bone marrow transplantation [letter], Blood, 81(3), 865, 1 Feb 1993
 - Press O W, Eary J, Appelbaum F R, Badger C C, Bernstein I D, Radiolabeled antibody therapy of lymphoma., Cancer Treatment and Research, 66, 127-45, 1993
 - Press O W, Eary J, Badger C C, Appelbaum F R, Wiseman G, Matthews D, Martin P J, Bernstein I D, High-dose radioimmunotherapy of lymphomas., Cancer Treatment and Research, 68, 13-22, 1993
 - Schuening F G, Appelbaum F R, Deeg H J, Sullivan-Pepe M, Graham T C, Hackman R, Zsebo K M, Storb R, Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation., Blood, 81(1), 20-6, 1 Jan 1993
 - Andrews R G, Bensinger W I, Knitter G H, Bartelmez S H, Longin K, Bernstein I D, Appelbaum F R, Zsebo K M, The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons., Blood, 80(11), 2715-20, 1 Dec 1992
 - Raff R F, Storb R, Graham T, Sale G, Shulman H, Pepe M, Deeg H J, Schuening F, Appelbaum F R, Fidler J M, et al, Succinyl acetone plus methotrexate as graft-versus-host disease prophylaxis in DLA-haploidentical canine littermate marrow grafts [comment], Transplantation, 54(5), 947-8, November 1992
 - Anasetti C, Martin P J, Storb R, Appelbaum F R, Beatty P G, Davis J, Doney K, Hill H F, Stewart P, Sullivan K M, et al, Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody., Transplantation, 54(5), 844-51, November 1992
 - Appelbaum F R, Matthews D C, Eary J F, Badger C C, Kellogg M, Press O W, Martin P J, Fisher D R, Nelp W B, Thomas E D, et al, The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia., Transplantation, 54(5), 829-33, November 1992
 - Raff R F, Storb R, Graham T, Fidler J M, Sale G E, Johnston B, Deeg H J, Pepe M, Schuening F, Appelbaum F R, et al, Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone [see comments], Transplantation, 54(5), 813-20, November 1992
 - Clift R A, Buckner C D, Appelbaum F R, Schoch G, Petersen F B, Bensinger W I, Sanders J, Sullivan K M, Storb R, Singer J, et al, Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia., Journal of Clinical Oncology, 10(11), 1723-9, November 1992
 - Nash R A, Pepe M S, Storb R, Longton G, Pettinger M, Anasetti C, Appelbaum F R, Bowden R A, Deeg H J, Doney K, et al, Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate [see comments], Blood, 80(7), 1838-45, 1 Oct 1992
 - Appelbaum F R, Brown P A, Sandmaier B M, Storb R, Fisher D R, Shulman H M, Graham T C, Schuening F G, Deeg H J, Bianco J A, et al, Specific marrow ablation before marrow transplantation using an aminophosphonic acid conjugate 166Ho-EDTMP., Blood, 80(6), 1608-13, 15 Sep 1992
 - Bensinger W I, Buckner C D, Clift R A, Petersen F B, Bianco J A, Singer J W, Appelbaum F R, Dalton W, Beatty P, Fefer A, et al, Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma., Journal of Clinical Oncology, 10(9), 1492-7, September 1992
 - Andrews R G, Bartelmez S H, Knitter G H, Myerson D, Bernstein I D, Appelbaum F R, Zsebo K M, A c-kit ligand, recombinant human stem cell factor, mediates reversible expansion of multiple CD34+ colony-forming cell types in blood and marrow of baboons., Blood, 80(4), 920-7, 15 Aug 1992
 - Grossbard M L, Press O W, Appelbaum F R, Bernstein I D, Nadler L M, Monoclonal antibody-based therapies of leukemia and lymphoma., Blood, 80(4), 863-78, 15 Aug 1992
 - Storb R, Pepe M, Deeg H J, Anasetti C, Appelbaum F R, Bensinger W, Buckner C D, Cliff R A, Doney K, Hansen J, et al, Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-id, Blood, 80(2), 560-1, 15 Jul 1992
 - Petersen F B, Buckner C D, Appelbaum F R, Sanders J E, Bensinger W I, Storb R, Deeg H J, Witherspoon R P, Sullivan K M, Clift R A, et al, Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study., Bone Marrow Transplantation, 10(1), 83-8, July 1992
 - Storb R, Martin P, Deeg H J, Sanders J E, Pepe M, Singer J, Anasetti C, Stewart P, Appelbaum F R, Sullivan K M, et al, Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia [letter], Blood, 79(11), 3091-2, 1 Jun 1992
 - Doney K, Pepe M, Storb R, Bryant E, Anasetti C, Appelbaum F R, Buckner C D, Sanders J, Singer J, Sullivan K, et al, Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, Blood, 79(10), 2566-71, 15 May 1992
 - Matthews D C, Badger C C, Fisher D R, Hui T E, Nourigat C, Appelbaum F R, Martin P J, Bernstein I D, Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody., Cancer Research, 52(5), 1228-34, 1 Mar 1992
 - Flowers M E, Doney K C, Storb R, Deeg H J, Sanders J E, Sullivan K M, Bryant E, Witherspoon R P, Appelbaum F R, Buckner C D, et al, Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience., Bone Marrow Transplantation, 9(3), 167-73, March 1992
 - van der Jagt R H, Badger C C, Appelbaum F R, Press O W, Matthews D C, Eary J F, Krohn K A, Bernstein I D, Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor model., Cancer Research, 52(1), 89-94, 1 Jan 1992
 - Appelbaum F R, Badger C C, Bernstein I D, Buckner C D, Deeg H J, Eary J F, Matthews D C, Press O W, Storb R, Thomas E D, Is there a better way to deliver total body irradiation?, Bone Marrow Transplantation, 10 Suppl 1, 77-81, 1992
 - Storb R, Longton G, Anasetti C, Appelbaum F R, Beatty P, Bensinger W, Crawford S, Deeg H J, Doney K, Fefer A, et al, Changing trends in marrow transplantation for aplastic anemia., Bone Marrow Transplantation, 10 Suppl 1, 45-52, 1992
 - Sullivan K M, Mori M, Sanders J, Siadak M, Witherspoon R P, Anasetti C, Appelbaum F R, Bensinger W, Bowden R, Buckner C D, et al, Late complications of allogeneic and autologous marrow transplantation., Bone Marrow Transplantation, 10 Suppl 1, 127-34, 1992
 - Petersen F B, Deeg H J, Buckner C D, Appelbaum F R, Storb R, Clift R A, Sanders J E, Bensinger W I, Witherspoon R P, Sullivan K M, et al, Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial., International Journal of Radiation Oncology, Biology, Physics, 23(5), 1027-32, 1992
 - Bean M A, Storb R, Graham T, Raff R, Sale G E, Schuening F, Appelbaum F R, Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DLA-identical canine marrow grafts by gamma irradiation of marrow donor blood., Transplantation, 52(6), 956-60, December 1991
 - Schuening F G, Kawahara K, Miller A D, To R, Goehle S, Stewart D, Mullally K, Fisher L, Graham T C, Appelbaum F R, et al, Retrovirus-mediated gene transduction into long-term repopulating marrow cells of dogs., Blood, 78(10), 2568-76, 15 Nov 1991
 - Badger C C, Davis J, Nourigat C, Wu Z M, Hui T E, Fisher D R, Shulman H, Appelbaum F R, Eary J F, Krohn K A, et al, Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I., Cancer Research, 51(21), 5921-8, 1 Nov 1991
 - Greinix H T, Ladiges W C, Graham T C, Maslan S, Raff R F, Sandmaier B M, Appelbaum F R, Schuening F G, Deeg H J, Storb R, Late failure of autologous marrow grafts in lethally irradiated dogs given anti-class II monoclonal antibody., Blood, 78(8), 2131-8, 15 Oct 1991
 - Andrews R G, Knitter G H, Bartelmez S H, Langley K E, Farrar D, Hendren R W, Appelbaum F R, Bernstein I D, Zsebo K M, Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates., Blood, 78(8), 1975-80, 15 Oct 1991
 - Matthews D C, Appelbaum F R, Eary J F, Hui T E, Fisher D R, Martin P J, Durack L D, Nelp W B, Press O W, Badger C C, et al, Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque., Blood, 78(7), 1864-74, 1 Oct 1991
 - Appelbaum F R, Radiolabeled monoclonal antibodies in the treatment of non-Hodgkin's lymphoma., hematology/oncology Clinics of North America, 5(5), 1013-25, October 1991
 - Van der Jagt R H, Appelbaum F R, Petersen F B, Bigelow C L, Fisher L D, Schoch G H, Buckner C D, Sanders J E, Storb R, Sullivan K M, et al, Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy., Bone Marrow Transplantation, 8(3), 211-5, September 1991
 - Bianco J A, Appelbaum F R, Nemunaitis J, Almgren J, Andrews F, Kettner P, Shields A, Singer J W, Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation [published erratum appears in Blood 1992 Jun 15;79(12):3397] [see comments], Blood, 78(5), 1205-11, 1 Sep 1991
 - Storb R, Sanders J E, Pepe M, Anasetti C, Appelbaum F R, Buckner C D, Deeg H J, Doney K, Hansen J, Martin P, et al, Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts [letter], Blood, 78(4), 1144-5, 15 Aug 1991
 - Buckner C D, Clift R A, Appelbaum F R, Storb R, Fefer A, Petersen F B, Sanders J E, Sullivan K, Thomas E D, Hansen J A, Effects of treatment regimens on post marrow transplant relapse., Seminars In Hematology, 28(3 Suppl 4), 32-4, July 1991
 - Doney K, Fisher L D, Appelbaum F R, Buckner C D, Storb R, Singer J, Fefer A, Anasetti C, Beatty P, Bensinger W, et al, Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survi, Bone Marrow Transplantation, 7(6), 453-9, June 1991
 - Nemunaitis J, Buckner C D, Appelbaum F R, Higano C S, Mori M, Bianco J, Epstein C, Lipani J, Hansen J, Storb R, et al, Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation., Blood, 77(9), 2065-71, 1 May 1991
 - Anasetti C, Martin P J, Storb R, Appelbaum F R, Beatty P G, Calori E, Davis J, Doney K, Reichert T, Stewart P, et al, Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3., Bone Marrow Transplantation, 7(5), 375-81, May 1991
 - Saikevych I A, Kerrigan D P, McConnell T S, Head D R, Appelbaum F R, Willman C L, Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chr, Leukemia, 5(5), 373-82, May 1991
 - Martin P J, Schoch G, Fisher L, Byers V, Appelbaum F R, McDonald G B, Storb R, Hansen J A, A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment., Blood, 77(8), 1821-8, 15 Apr 1991
 - Clift R A, Buckner C D, Appelbaum F R, Bryant E, Bearman S I, Petersen F B, Fisher L D, Anasetti C, Beatty P, Bensinger W I, et al, Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens., Blood, 77(8), 1660-5, 15 Apr 1991
 - Storb R, Bean M A, Appelbaum F R, Schuening F G, Graham T C, Raff R F, Treatment of marrow donor blood products with gamma-irradiation prevents transfusion-induced sensitization to DLA-identical marrow grafts., Transplantation Proceedings, 23(1 Pt 2), 1697-8, February 1991
 - Press O W, Eary J F, Badger C C, Martin P J, Appelbaum F R, Nelp W B, Levy R, Miller R, Fisher D, Matthews D, et al, Radiolabeled antibody therapy of human B cell lymphomas., Advances In Experimental Medicine and Biology, 303, 91-6, 1991
 - Buckner C D, Clift R A, Appelbaum F R, Storb R, Petersen F B, Sanders J E, Thomas E D, Hansen J A, Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia., Bone Marrow Transplantation, 7 Suppl 2, 6-8, 1991
 - Nemunaitis J, Singer J W, Buckner C D, Mori T, Laponi J, Hill R, Storb R, Sullivan K M, Hansen J A, Appelbaum F R, Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy., Bone Marrow Transplantation, 7(1), 49-52, January 1991
 - Clift R A, Buckner C D, Appelbaum F R, Bearman S I, Petersen F B, Fisher L D, Anasetti C, Beatty P, Bensinger W I, Doney K, et al, Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens [see comments], Blood, 76(9), 1867-71, 1 Nov 1990
 - Loughran T P Jr, Raff R F, Graham T C, Appelbaum F R, Schuening F G, Sale G E, Storb R, Transfusion of autologous cytotoxic cells leads to failure of unrelated, DLA-nonidentical marrow grafts., Experimental Hematology, 18(10), 1126-31, November 1990
 - Martin P J, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum F R, Beatty P G, Doney K, McDonald G B, Sanders J E, et al, A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment., Blood, 76(8), 1464-72, 15 Oct 1990
 - Storb R, Pepe M, Anasetti C, Appelbaum F R, Beatty P, Doney K, Martin P, Stewart P, Sullivan K M, Witherspoon R, et al, What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?, Blood, 76(5), 1037-45, 1 Sep 1990
 - Schuening F G, Storb R, Goehle S, Graham T C, Hackman R, Mori M, Souza L M, Appelbaum F R, Recombinant human granulocyte colony-stimulating factor accelerates hematopoietic recovery after DLA-identical littermate marrow transplants in dogs., Blood, 76(3), 636-40, 1 Aug 1990
 - Sandmaier B M, Storb R, Appelbaum F R, Gallatin W M, An antibody that facilitates hematopoietic engraftment recognizes CD44., Blood, 76(3), 630-5, 1 Aug 1990
 - Appelbaum F R, Introduction and overview of interferon alfa in myeloproliferative and hemangiomatous diseases., Seminars In Hematology, 27(3 Suppl 4), 1-5, July 1990
 - Nemunaitis J, Singer J W, Buckner C D, Durnam D, Epstein C, Hill R, Storb R, Thomas E D, Appelbaum F R, Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation., Blood, 76(1), 245-53, 1 Jul 1990
 - Anasetti C, Martin P J, Hansen J A, Appelbaum F R, Beatty P G, Doney K, Harkonen S, Jackson A, Reichert T, Stewart P, et al, A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease., Transplantation, 50(1), 49-54, July 1990
 - Niederwieser D W, Appelbaum F R, Gastl G, Gersdorf E, Meister B, Geissler D, Tratkiewicz J A, Thaler J, Huber C, Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia., New England Journal of Medicine, 322(25), 1794-6, 21 Jun 1990
 - Bianco J A, Higano C, Singer J, Appelbaum F R, McDonald G B, The somatostatin analog octreotide in the management of the secretory diarrhea of the acute intestinal graft-versus-host disease in a patient after bone marrow transplantation., Transplantation, 49(6), 1194-5, June 1990
 - Sullivan K M, Appelbaum F R, Comparative trials of chemotherapy and bone marrow transplantation in acute nonlymphocytic leukemia., Rinsho ketsueki. Japanese Journal of Clinical Hematology, 31(5), 527-33, May 1990
 - Appelbaum F R, Barrall J, Storb R, Fisher L D, Schoch G, Ramberg R E, Shulman H, Anasetti C, Bearman S I, Beatty P, et al, Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome., Annals of Internal Medicine, 112(8), 590-7, 15 Apr 1990
 - Bianco J A, Appelbaum F R, Biotherapy after marrow transplantation and the use of hematopoietic growth factors., Current Opinion In Oncology, 2(2), 289-96, April 1990
 - Petersen F B, Appelbaum F R, Hill R, Fisher L D, Bigelow C L, Sanders J E, Sullivan K M, Bensinger W I, Witherspoon R P, Storb R, et al, Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle., Journal of Clinical Oncology, 8(4), 638-47, April 1990
 - Bearman S I, Petersen F B, Schor R A, Denney J D, Fisher L D, Appelbaum F R, Buckner C D, Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity., Bone Marrow Transplantation, 5(3), 173-7, March 1990
 - Bernstein I D, Eary J F, Badger C C, Press O W, Appelbaum F R, Martin P J, Krohn K A, Nelp W B, Porter B, Fisher D, et al, High dose radiolabeled antibody therapy of lymphoma., Cancer Research, 50(3 Suppl), 1017s-1021s, 1 Feb 1990
 - Appelbaum F R, Bone marrow transplantation for acute nonlymphocytic leukemia (ANL)., Cancer Treatment and Research, 50, 201-22, 1990
 - Press O W, Eary J F, Badger C C, Martin P J, Appelbaum F R, Nelp W B, Krohn K A, Fisher D, Porter B, Thomas E D, et al, High-dose radioimmunotherapy of B cell lymphomas., Frontiers of Radiation Therapy and Oncology, 24, 204-13; discussion 2, 1990
 - Appelbaum F R, Nemunaitis J, Singer J W, Buckner C D, Storb R, Thomas E D, Use of recombinant human granulocyte macrophage colony-stimulating factor to speed engraftment and treat graft failure following marrow transplantation in man., Hamatologie Und Bluttransfusion, 33, 736-40, 1990
 - Storb R, Buckner C D, Clift R A, Appelbaum F R, Doney K C, Martin P, Anasetti C, Hansen J, Sanders J E, Petersen F B, et al, Marrow grafting for acute leukemia: results and future treatment strategies., Hamatologie Und Bluttransfusion, 33, 629-35, 1990
 - Sullivan K M, Meyers J, Petersen F B, Bowden R, Counts G C, Banaji M, Schubert M, Clark J, Clift R A, Appelbaum F R, et al, Supportive care of the marrow transplant recipient: the Seattle Experience., Hamatologie Und Bluttransfusion, 33, 539-45, 1990
 - Bigelow C L, Adler L T, Appelbaum F R, Impact of RLA matching and cyclosporine on long-term survival in transplanted rabbits., Experimental Hematology, 18(1), 3-6, January 1990
 - Ladiges W C, Storb R, Raff R F, Appelbaum F R, Sandmaier B, Schuening F, Graham T, Failure of anti-MHC antibodies to prevent GVHD in DLA mismatched unrelated canine marrow recipients., Bone Marrow Transplantation, 5(1), 43-6, January 1990
 - Appelbaum F R, Buckner C D, Marrow transplantation for patients with severe myelodysplasia., Bone Marrow Transplantation, 4 Suppl 3, 40, December 1989
 - Petersen FB, Buckner CD, Appelbaum FR, Clift RA, Sanders JE, Bensinger WI, Storb R, Witherspoon RP, Sullivan KM, Bearman SI, et al., Busulfan, cyclophosphamide and fractionated total body irradiation as a
preparatory regimen for marrow transplantation in patients with advanced
hematological malignancies: a phase I study, Bone Marrow Transplantation, 4(6), 617-23, Nov 1989
 - Appelbaum F R, Marrow transplantation in the treatment of patients with lymphoma., Current Opinion In Oncology, 1(1), 47-54, October 1989
 - Bearman SI, Appelbaum FR, Back A, Petersen FB, Buckner CD, Sullivan KM, Schoch HG, Fisher LD, Thomas ED, Regimen-related toxicity and early posttransplant survival in patients
undergoing marrow transplantation for lymphoma, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 7(9), 1288-94, Sep 1989
 - Petersen FB, Appelbaum FR, Bigelow CL, Buckner CD, Clift RA, Sanders JE, Storb R, Sullivan KM, Weiden PL, Fefer A, et al., High-dose cytosine arabinoside, total body irradiation and marrow
transplantation for advanced malignant lymphoma, Bone Marrow Transplantation, 4(5), 483-8, Sep 1989
 - Press OW, Eary JF, Badger CC, Martin PJ, Appelbaum FR, Levy R, Miller R, Brown S, Nelp WB, Krohn KA, et al., Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1
(anti-CD37) antibody, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 7(8), 1027-38, Aug 1989
 - Appelbaum FR, The clinical use of hematopoietic growth factors, Seminars in Hematology, 26(3 Suppl 3), 7-14, Jul 1989
 - Appelbaum F R, Raff R F, Storb R, Deeg H J, Graham T C, Sandmaier B, Schuening F, Use of trimetrexate for the prevention of graft-versus-host disease., Bone Marrow Transplantation, 4(4), 421-4, July 1989
 - Appelbaum FR, Brown P, Sandmaier B, Badger C, Schuening F, Graham T, Storb R, Antibody-radionuclide conjugates as part of a myeloablative preparative
regimen for marrow transplantation, Blood, 73(8), 2202-8, Jun 1989
 - Sullivan K M, Weiden P L, Storb R, Witherspoon R P, Fefer A, Fisher L, Buckner C D, Anasetti C, Appelbaum F R, Badger C, et al, Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published err, Blood, 73(6), 1720-8, 1 May 1989
 - Sullivan K M, Storb R, Buckner C D, Fefer A, Fisher L, Weiden P L, Witherspoon R P, Appelbaum F R, Banaji M, Hansen J, et al, Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms., New England Journal of Medicine, 320(13), 828-34, 30 Mar 1989
 - Tallman M S, Kopecky K J, Amos D, Dahlberg S, Hewlett J S, Files J C, Coltman C A, Thomas E D, Appelbaum F R, Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission., Journal of Clinical Oncology, 7(3), 326-37, March 1989
 - Anasetti C, Amos D, Beatty P G, Appelbaum F R, Bensinger W, Buckner C D, Clift R, Doney K, Martin P J, Mickelson E, et al, Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma., New England Journal of Medicine, 320(4), 197-204, 26 Jan 1989
 - Buckner C D, Sanders J, Appelbaum F R, Allogeneic marrow transplantation for acute non-lymphoblastic leukemia: first remission versus after first relapse., Bone Marrow Transplantation, 4 Suppl 1, 244-6, January 1989
 - Hill R S, Mazza P, Amos D, Buckner C D, Appelbaum F R, Martin P, Still B J, Sica S, Berenson R, Bensinger W, et al, Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation., Bone Marrow Transplantation, 4(1), 69-74, January 1989
 - Mortimer J, Blinder M A, Schulman S, Appelbaum F R, Buckner C D, Clift R A, Sanders J E, Storb R, Thomas E D, Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy [published erratum appears in J Clin Oncol 1989 Apr;7(4):545], Journal of Clinical Oncology, 7(1), 50-7, January 1989
 - Sullivan KM, Buckner CD, Sanders JE, Anasetti C, Appelbaum FR, Clark J, Doney K, Meyers J, Sale G, Storb R, et al., Long-term complications of bone marrow transplantation, Progress in Clinical and Biological Research, 309, 367-74, 1989
 - Buckner CD, Fefer A, Bensinger WI, Storb R, Durie BG, Appelbaum FR, Petersen FB, Weiden P, Clift RA, Sanders JE, et al., Marrow transplantation for malignant plasma cell disorders: summary of the
Seattle experience, European Journal of Haematology. Supplementum, 51, 186-90, 1989
 - Martin PJ, Clift RA, Fisher LD, Buckner CD, Hansen JA, Appelbaum FR, Doney KC, Sullivan KM, Witherspoon RP, Storb R, et al., HLA-identical marrow transplantation during accelerated-phase chronic
myelogenous leukemia: analysis of survival and remission
duration, Blood, 72(6), 1978-84, Dec 1988
 - Petersen FB, Appelbaum FR, Buckner CD, Sanders JE, Clift RA, McGuffin R, Bearman SI, Flournoy N, Thomas ED, Simultaneous infusion of high-dose cytosine arabinoside with
cyclophosphamide followed by total body irradiation and marrow infusion
for the treatment of patients with advanced hematologic, Bone Marrow Transplantation, 3(6), 619-24, Nov 1988
 - Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA, Thomas ED, Regimen-related toxicity in patients undergoing bone marrow
transplantation, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 6(10), 1562-8, Oct 1988
 - Appelbaum FR, Intensive chemotherapy or chemoradiotherapy with autologous marrow support
as treatment for patients with solid tumors, Hematology/oncology Clinics of North America, 2(3), 345-52, Sep 1988
 - Appelbaum FR, Nemunaitis J, Recombinant human granulocyte macrophage colony stimulating factor
(rhGM-CSF) following autologous marrow transplantation in
man, Behring Institute Mitteilungen, 145-8, Aug 1988
 - Nemunaitis J, Singer JW, Buckner CD, Hill R, Storb R, Thomas ED, Appelbaum FR, Use of recombinant human granulocyte-macrophage colony-stimulating factor
in autologous marrow transplantation for lymphoid malignancies, Blood, 72(2), 834-6, Aug 1988
 - Sullivan KM, Witherspoon RP, Storb R, Weiden P, Flournoy N, Dahlberg S, Deeg HJ, Sanders JE, Doney KC, Appelbaum FR, et al., Prednisone and azathioprine compared with prednisone and placebo for
treatment of chronic graft-v-host disease: prognostic influence of
prolonged thrombocytopenia after allogeneic marrow
, Blood, 72(2), 546-54, Aug 1988
 - Sullivan KM, Witherspoon RP, Storb R, Deeg HJ, Dahlberg S, Sanders JE, Appelbaum FR, Doney KC, Weiden P, Anasetti C, et al., Alternating-day cyclosporine and prednisone for treatment of high-risk
chronic graft-v-host disease, Blood, 72(2), 555-61, Aug 1988
 - Appelbaum FR, Marrow transplantation for hematologic malignancies: a brief review of
current status and future prospects, Seminars in Hematology, 25(3 Suppl 3), 16-22, Jul 1988
 - Appelbaum FR, Fisher LD, Thomas ED, Chemotherapy v marrow transplantation for adults with acute nonlymphocytic
leukemia: a five-year follow-up, Blood, 72(1), 179-84, Jul 1988
 - Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K, Storb R, Sullivan KM, Witherspoon RP, Thomas ED, Ovarian function following marrow transplantation for aplastic anemia or
leukemia, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 6(5), 813-8, May 1988
 - Appelbaum FR, Reply to Z. Arlin "Bone marrow transplantation for chronic myelogenous
leukemia: some thoughts about future prospects", Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 2(4), 251-2, Apr 1988
 - Appelbaum FR, Graham T, Sandmaier B, Schuening F, Storb R, Sensitivity of newly transplanted marrow to further irradiation, Transplantation, 45(4), 813-4, Apr 1988
 - Riddell S, Appelbaum FR, Buckner CD, Stewart P, Clift R, Sanders J, Storb R, Sullivan K, Thomas ED, High-dose cytarabine and total body irradiation with or without
cyclophosphamide as a preparative regimen for marrow transplantation for
acute leukemia, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 6(4), 576-82, Apr 1988
 - Tallman MS, Nemunaitis JJ, McGuire TR, Yee GC, Hughes TE, Almgren JD, Appelbaum FR, Higano CS, McGuffin RW, Singer JW, et al., Comparison of two intravenous cyclosporine infusion schedules in marrow
transplant recipients, Transplantation, 45(4), 810-3, Apr 1988
 - Tricot GJ, Lauer RC, Appelbaum FR, Jansen J, Hoffman R, Management of the myelodysplastic syndromes, Seminars in Oncology, 14(4), 444-53, Dec 1987
 - Appelbaum FR, Barrall J, Storb R, Ramberg R, Doney K, Sale GE, Thomas ED, Clonal cytogenetic abnormalities in patients with otherwise typical
aplastic anemia, Experimental Hematology, 15(11), 1134-9, Dec 1987
 - Meyers JD, Flournoy N, Sanders JE, McGuffin RW, Newton BA, Fisher LD, Lum LG, Appelbaum FR, Doney K, Sullivan KM, et al., Prophylactic use of human leukocyte interferon after allogeneic marrow
transplantation, Annals of Internal Medicine, 107(6), 809-16, Dec 1987
 - Doney K, Buckner CD, Kopecky KJ, Sanders JE, Appelbaum FR, Clift R, Sullivan K, Witherspoon R, Storb R, Thomas ED, Marrow transplantation for patients with acute lymphoblastic leukemia in
first marrow remission, Bone Marrow Transplantation, 2(4), 355-63, Dec 1987
 - Sale GE, Rajantie J, Doney K, Appelbaum FR, Storb R, Thomas ED, Does histologic grading of inflammation in bone marrow predict the
response of aplastic anaemia patients to antithymocyte globulin
therapy?, British Journal of Haematology, 67(3), 261-6, Nov 1987
 - Schuening F, Storb R, Goehle S, Meyer J, Graham TC, Deeg HJ, Appelbaum FR, Sale GE, Graf L, Loughran TP Jr, Facilitation of engraftment of DLA-nonidentical marrow by treatment of
recipients with monoclonal antibody directed against marrow cells
surviving radiation, Transplantation, 44(5), 607-13, Nov 1987
 - Appelbaum FR, Marrow transplantation for malignant lymphoma, Bone Marrow Transplantation, 2(3), 227-31, Oct 1987
 - Clift RA, Buckner CD, Thomas ED, Kopecky KJ, Appelbaum FR, Tallman M, Storb R, Sanders J, Sullivan K, Banaji M, et al., The treatment of acute non-lymphoblastic leukemia by allogeneic marrow
transplantation, Bone Marrow Transplantation, 2(3), 243-58, Oct 1987
 - Bigelow CL, Adler LT, Appelbaum FR, Allogeneic bone marrow transplantation in irradiated adult rabbits, Transplantation, 44(3), 351-4, Sep 1987
 - Deeg HJ, Sale GE, Storb R, Graham TC, Schuening F, Appelbaum FR, Thomas ED, Engraftment of DLA-nonidentical bone marrow facilitated by recipient
treatment with anti-class II monoclonal antibody and
methotrexate, Transplantation, 44(3), 340-5, Sep 1987
 - Appelbaum FR, Sullivan KM, Buckner CD, Clift RA, Deeg HJ, Fefer A, Hill R, Mortimer J, Neiman PE, Sanders JE, et al., Treatment of malignant lymphoma in 100 patients with chemotherapy, total
body irradiation, and marrow transplantation, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 5(9), 1340-7, Sep 1987
 - Storb R, Weiden PL, Sullivan KM, Appelbaum FR, Beatty P, Buckner CD, Clift RA, Doney KC, Hansen J, Martin PJ, et al., Second marrow transplants in patients with aplastic anemia rejecting the
first graft: use of a conditioning regimen including cyclophosphamide and
antithymocyte globulin, Blood, 70(1), 116-21, Jul 1987
 - Tallman MS, Appelbaum FR, Amos D, Goldberg RS, Livingston RB, Mortimer J, Weiden PL, Thomas ED, Evaluation of intensive postremission chemotherapy for adults with acute
nonlymphocytic leukemia using high-dose cytosine arabinoside with
L-asparaginase and amsacrine with etoposide, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 5(6), 918-26, Jun 1987
 - Dulley FL, Kanfer EJ, Appelbaum FR, Amos D, Hill RS, Buckner CD, Shulman HM, McDonald GB, Thomas ED, Venocclusive disease of the liver after chemoradiotherapy and autologous
bone marrow transplantation, Transplantation, 43(6), 870-3, Jun 1987
 - Sargur M, Buckner CD, Appelbaum FR, Stewart P, Deeg HJ, Weiden PL, Sullivan KM, Fefer A, Thomas ED, Marrow transplantation for acute nonlymphocytic leukemia following therapy
for Hodgkin's disease, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 5(5), 731-4, May 1987
 - Kanfer EJ, Buckner CD, Fefer A, Storb R, Appelbaum FR, Hill RS, Amos D, Doney KC, Clift RA, Shulman HM, et al., Allogeneic and syngeneic marrow transplantation following high dose
dimethylbusulfan, cyclophosphamide and total body irradiation, Bone Marrow Transplantation, 1(4), 339-46, Apr 1987
 - Appelbaum FR, Thomas ED, Bone marrow transplantation for malignant lymphoma, European Journal of Cancer & Clinical Oncology, 23(3), 263-6, Mar 1987
 - Doney K, Storb R, Buckner CD, McGuffin R, Witherspoon R, Deeg HJ, Appelbaum FR, Sullivan KM, Thomas ED, Treatment of aplastic anemia with antithymocyte globulin, high-dose
corticosteroids, and androgens, Experimental Hematology, 15(3), 239-42, Mar 1987
 - Shields AF, Porter BA, Churchley S, Olson DO, Appelbaum FR, Thomas ED, The detection of bone marrow involvement by lymphoma using magnetic
resonance imaging, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 5(2), 225-30, Feb 1987
 - Storb R, Deeg HJ, Whitehead J, Farewell V, Appelbaum FR, Beatty P, Bensinger W, Buckner CD, Clift RA, Doney K, et al., Marrow transplantation for leukemia and aplastic anemia: two controlled
trials of a combination of methotrexate and cyclosporine v cyclosporine
alone or methotrexate alone for prophylaxis, Transplantation Proceedings, 19(1 Pt 3), 2608-13, Feb 1987
 - Appelbaum FR, Badger CC, Deeg HJ, Nelp WB, Storb R, Use of iodine-131-labeled anti-immune response-associated monoclonal
antibody as preparative regimen prior to bone marrow transplantation:
initial dosimetry, Nci Monographs : a Publication of the National Cancer Institute, 67-71, 1987
 - Kanfer EJ, Petersen FB, Buckner CD, Stewart P, Storb R, Hill RS, Appelbaum FR, Clift RA, Doney KC, Shulman HM, et al., Phase I study of high-dose dimethylbusulfan followed by autologous bone
marrow transplantation in patients with advanced malignancy, Cancer Treatment Reports, 71(1), 101-2, Jan 1987
 - Appelbaum FR, Storb R, Ramberg RE, Shulman HM, Buckner CD, Clift RA, Deeg HJ, Fefer A, Sanders J, Self S, et al., Treatment of preleukemic syndromes with marrow transplantation, Blood, 69(1), 92-6, Jan 1987
 - Deeg HJ, Sullivan KM, Buckner CD, Storb R, Appelbaum FR, Clift RA, Doney K, Sanders JE, Witherspoon RP, Thomas ED, Marrow transplantation for acute nonlymphoblastic leukemia in first
remission: toxicity and long-term follow-up of patients conditioned with
single dose or fractionated total body irradiat, Bone Marrow Transplantation, 1(2), 151-7, Dec 1986
 - Deeg HJ, Self S, Storb R, Doney K, Appelbaum FR, Witherspoon RP, Sullivan KM, Sheehan K, Sanders J, Mickelson E, et al., Decreased incidence of marrow graft rejection in patients with severe
aplastic anemia: changing impact of risk factors, Blood, 68(6), 1363-8, Dec 1986
 - Pecego R, Hill R, Appelbaum FR, Amos D, Buckner CD, Fefer A, Thomas ED, Interstitial pneumonitis following autologous bone marrow transplantation, Transplantation, 42(5), 515-7, Nov 1986
 - Sanders JE, Pritchard S, Mahoney P, Amos D, Buckner CD, Witherspoon RP, Deeg HJ, Doney KC, Sullivan KM, Appelbaum FR, et al., Growth and development following marrow transplantation for leukemia, Blood, 68(5), 1129-35, Nov 1986
 - Bolger GB, Sullivan KM, Spence AM, Appelbaum FR, Johnston R, Sanders JE, Deeg HJ, Witherspoon RP, Doney KC, Nims J, et al., Myasthenia gravis after allogeneic bone marrow transplantation:
relationship to chronic graft-versus-host disease, Neurology, 36(8), 1087-91, Aug 1986
 - Appelbaum FR, Deeg HJ, Storb R, Graham TC, Charrier K, Bensinger W, Cure of malignant lymphoma in dogs with peripheral blood stem cell
transplantation, Transplantation, 42(1), 19-22, Jul 1986
 - Lensink DB, Barton A, Appelbaum FR, Hammond WP 4th, Cyclic neutropenia as a premalignant manifestation of acute lymphoblastic
leukemia, American Journal of Hematology, 22(1), 9-16, May 1986
 - Klingemann HG, Storb R, Sanders J, Deeg HJ, Appelbaum FR, Thomas ED, Acute lymphoblastic leukaemia after bone marrow transplantation for
aplastic anaemia, British Journal of Haematology, 63(1), 47-50, May 1986
 - Anasetti C, Doney KC, Storb R, Meyers JD, Farewell VT, Buckner CD, Appelbaum FR, Sullivan KM, Clift RA, Deeg HJ, et al., Marrow transplantation for severe aplastic anemia. Long-term outcome in
fifty "untransfused" patients, Annals of Internal Medicine, 104(4), 461-6, Apr 1986
 - Hill RS, Petersen FB, Storb R, Appelbaum FR, Doney K, Dahlberg S, Ramberg R, Thomas ED, Mixed hematologic chimerism after allogeneic marrow transplantation for
severe aplastic anemia is associated with a higher risk of graft rejection
and a lessened incidence of acute graft-v, Blood, 67(3), 811-6, Mar 1986
 - Klingemann HG, Storb R, Fefer A, Deeg HJ, Appelbaum FR, Buckner CD, Cheever MA, Greenberg PD, Stewart PS, Sullivan KM, et al., Bone marrow transplantation in patients aged 45 years and older, Blood, 67(3), 770-6, Mar 1986
 - Appelbaum FR, Buckner CD, Overview of the clinical relevance of autologous bone marrow
transplantation, Clinics in Haematology, 15(1), 1-18, Feb 1986
 - Deeg HJ, Aprile J, Graham TC, Appelbaum FR, Storb R, Ultraviolet irradiation of blood prevents transfusion-induced
sensitization and marrow graft rejection in dogs, Blood, 67(2), 537-9, Feb 1986
 - Thomas ED, Clift RA, Fefer A, Appelbaum FR, Beatty P, Bensinger WI, Buckner CD, Cheever MA, Deeg HJ, Doney K, et al., Marrow transplantation for the treatment of chronic myelogenous leukemia, Annals of Internal Medicine, 104(2), 155-63, Feb 1986
 - Sanders JE, Whitehead J, Storb R, Buckner CD, Clift RA, Mickelson E, Appelbaum FR, Bensinger WI, Stewart PS, Doney K, et al., Bone marrow transplantation experience for children with aplastic anemia, Pediatrics, 77(2), 179-86, Feb 1986
 - Appelbaum FR, Thomas ED, Crossing the bridge from hematologic malignancies to solid tumors, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 4(1), 2-3, Jan 1986
 - Sullivan KM, Appelbaum FR, Horning SJ, Rosenberg SA, Thomas ED, Selection of patients with Hodgkin's disease and non-Hodgkin's lymphoma
for bone marrow transplantation, International Journal of Cell Cloning, 4 Suppl 1, 94-106, 1986
 - Appelbaum FR, Sullivan KM, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Neiman PE, Sanders JE, Stewart P, Storb R, Allogeneic marrow transplantation in the treatment of MOPP-resistant
Hodgkin's disease, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 3(11), 1490-4, Nov 1985
 - Jin NR, Hill RS, Petersen FB, Buckner CD, Stewart PS, Amos D, Appelbaum FR, Clift RA, Bensinger WI, Sanders JE, et al., Marrow harvesting for autologous marrow transplantation, Experimental Hematology, 13(9), 879-84, Oct 1985
 - Martin PJ, Hansen JA, Buckner CD, Sanders JE, Deeg HJ, Stewart P, Appelbaum FR, Clift R, Fefer A, Witherspoon RP, et al., Effects of in vitro depletion of T cells in HLA-identical allogeneic
marrow grafts, Blood, 66(3), 664-72, Sep 1985
 - Storb R, Deeg HJ, Thomas ED, Appelbaum FR, Buckner CD, Cheever MA, Clift RA, Doney KC, Flournoy N, Kennedy MS, et al., Marrow transplantation for chronic myelocytic leukemia: a controlled trial
of cyclosporine versus methotrexate for prophylaxis of graft-versus-host
disease, Blood, 66(3), 698-702, Sep 1985
 - Deeg HJ, Loughran TP Jr, Storb R, Kennedy MS, Sullivan KM, Doney K, Appelbaum FR, Thomas ED, Treatment of human acute graft-versus-host disease with antithymocyte
globulin and cyclosporine with or without methylprednisolone, Transplantation, 40(2), 162-6, Aug 1985
 - Sanders JE, Thomas ED, Buckner CD, Flournoy N, Stewart PS, Clift RA, Lum L, Bensinger WI, Storb R, Appelbaum FR, et al., Marrow transplantation for children in first remission of acute
nonlymphoblastic leukemia: an update, Blood, 66(2), 460-2, Aug 1985
 - Deeg HJ, Storb R, Thomas ED, Flournoy N, Kennedy MS, Banaji M, Appelbaum FR, Bensinger WI, Buckner CD, Clift RA, et al., Cyclosporine as prophylaxis for graft-versus-host disease: a randomized
study in patients undergoing marrow transplantation for acute
nonlymphoblastic leukemia, Blood, 65(6), 1325-34, Jun 1985
 - Kennedy MS, Deeg HJ, Storb R, Doney K, Sullivan KM, Witherspoon RP, Appelbaum FR, Stewart P, Sanders J, Buckner CD, et al., Treatment of acute graft-versus-host disease after allogeneic marrow
transplantation. Randomized study comparing corticosteroids and
cyclosporine, The American Journal of Medicine, 78(6 Pt 1), 978-83, Jun 1985
 - Appelbaum FR, Thomas ED, Treatment of acute leukemia in adults with chemoradiotherapy and bone
marrow transplantation, Cancer, 55(9 Suppl), 2202-9, May 1985
 - Szer J, Deeg HJ, Appelbaum FR, Storb R, Failure of autologous marrow reconstitution after cytolytic treatment of
marrow with anti-Ia monoclonal antibody, Blood, 65(4), 819-22, Apr 1985
 - Appelbaum FR, Cheever MA, Fefer A, Storb R, Thomas ED, Recurrence of aplastic anemia following cyclophosphamide and syngeneic
bone marrow transplantation: evidence for two mechanisms of graft
failure, Blood, 65(3), 553-6, Mar 1985
 - Sanders JE, Flournoy N, Thomas ED, Buckner CD, Lum LG, Clift RA, Appelbaum FR, Sullivan KM, Stewart P, Deeg HJ, et al., Marrow transplant experience in children with acute lymphoblastic
leukemia: an analysis of factors associated with survival, relapse, and
graft-versus-host disease, Medical and Pediatric Oncology, 13(4), 165-72, 1985
 - Irle C, Deeg HJ, Buckner CD, Kennedy M, Clift R, Storb R, Appelbaum FR, Beatty P, Bensinger W, Doney K, et al., Marrow transplantation for leukemia following fractionated total body
irradiation. A comparative trial of methotrexate and
cyclosporine, Leukemia Research, 9(10), 1255-61, 1985
 - Thomas ED, Sanders JE, Buckner CD, Papayannopoulou T, Borgna-Pignatti C, De Stefano P, Sullivan KM, Deeg HJ, Witherspoon RP, Appelbaum FR, et al., Marrow transplantation for thalassemia, Annals of the New York Academy of Sciences, 445, 417-27, 1985
 - Cheever MA, Fefer A, Greenberg PD, Appelbaum FR, Armitage JO, Buckner CD, Sale GE, Storb R, Witherspoon RD, Thomas ED, Identical twin bone marrow transplantation for hairy cell leukemia, Seminars in Oncology, 11(4 Suppl 2), 511-3, December 1984
 - Appelbaum FR, Dahlberg S, Thomas ED, Buckner CD, Cheever MA, Clift RA, Crowley J, Deeg HJ, Fefer A, Greenberg PD, et al., Bone marrow transplantation or chemotherapy after remission induction for
adults with acute nonlymphoblastic leukemia. A prospective
comparison, Annals of Internal Medicine, 101(5), 581-8, Nov 1984
 - Buckner CD, Clift RA, Sanders JE, Stewart P, Bensinger WI, Doney KC, Sullivan KM, Witherspoon RP, Deeg HJ, Appelbaum FR, et al., Marrow harvesting from normal donors, Blood, 64(3), 630-4, Sep 1984
 - Appelbaum FR, Storb R, Ramberg RE, Shulman HM, Buckner CD, Clift RA, Deeg HJ, Fefer A, Sanders J, Stewart P, et al., Allogeneic marrow transplantation in the treatment of preleukemia, Annals of Internal Medicine, 100(5), 689-93, May 1984
 - Deeg HJ, Storb R, Appelbaum FR, Kennedy MS, Graham TC, Thomas ED, Combined immunosuppression with cyclosporine and methotrexate in dogs
given bone marrow grafts from DLA-haploidentical littermates, Transplantation, 37(1), 62-5, January 1984
 - Storb R, Thomas ED, Buckner CD, Appelbaum FR, Clift RA, Deeg HJ, Doney K, Hansen JA, Prentice RL, Sanders JE, et al., Marrow transplantation for aplastic anemia, Seminars in Hematology, 21(1), 27-35, January 1984
 - Sullivan KM, Deeg HJ, Sanders JE, Shulman HM, Witherspoon RP, Doney K, Appelbaum FR, Schubert MM, Stewart P, Springmeyer S, et al., Late complications after marrow transplantation, Seminars in Hematology, 21(1), 53-63, January 1984
 - Storb R, Thomas ED, Appelbaum FR, Clift RA, Deeg HJ, Doney K, Hansen JA, Prentice RL, Sanders JE, Singer JW, et al., Marrow transplantation for severe aplastic anemia: the Seattle experience, Progress in Clinical and Biological Research, 148, 297-313, 1984
 - Stewart P, Buckner CD, Thomas ED, Bagley C, Bensinger W, Clift RA, Appelbaum FR, Sanders J, Intensive chemoradiotherapy with autologous marrow transplantation for
small cell carcinoma of the lung, Cancer Treatment Reports, 67(12), 1055-9, December 1983
 - Storb R, Prentice RL, Thomas ED, Appelbaum FR, Deeg HJ, Doney K, Fefer A, Goodell BW, Mickelson E, Stewart P, et al., Factors associated with graft rejection after HLA-identical marrow
transplantation for aplastic anaemia, British Journal of Haematology, 55(4), 573-85, December 1983
 - Appelbaum FR, Thomas ED, Review of the use of marrow transplantation in the treatment of
non-Hodgkin's lymphoma, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 1(7), 440-7, July 1983
 - Sullivan KM, Neiman PE, Kadin ME, Dahlberg S, Farewell VT, Rudolph RH, Bagley CM Jr, Appelbaum FR, Thomas ED, Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis
of remission duration and survival in 95 patients, Blood, 62(1), 51-61, July 1983
 - Appelbaum FR, Clift RA, Buckner CD, Stewart P, Storb R, Sullivan KM, Thomas ED, Allogeneic marrow transplantation for acute nonlymphoblastic leukemia
after first relapse, Blood, 61(5), 949-53, May 1983
 - Appelbaum FR, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A, Neiman PE, Sanders J, Stewart P, Storb R, et al., Treatment of non-Hodgkin's lymphoma with chemoradiotherapy and allogenic
marrow transplantation, Hematological Oncology, 1(2), 149-57, Apr-J 1983
 - Storb R, Prentice RL, Banaji M, Witherspoon RP, Sullivan KM, Stewart P, Sanders JE, Mason M, Doney K, Deeg J, Clift RA, Buckner CD, Appelbaum FR, Thomas ED, Marrow transplantation from HLA-identical siblings for treatment of
aplastic anemia: is exposure to marrow donor blood products 24 hours
before high-dose cyclophosphamide needed for succes, Blood, 61(4), 672-5, Apr 1983
 - Appelbaum FR, Najfeld V, Singer JW, Chronic myelogenous leukemia. Prolonged survival with spontaneous decline
in the frequency of Ph1-positive cells and subsequent development of mixed
Ph1-positive and Ph1-negative blast cri, Cancer, 51(1), 149-53, Jan 1983
 - Kaplan HG, Appelbaum FR, Cheever MA, Greenberg PD, Wood T, Fefer A, Treatment of refractory acute nonlymphocytic leukemia with a combination
of pyrazofurin and cytarabine, Cancer Treatment Reports, 66(6), 1397-8, Jun 1982
 - Fefer A, Cheever MA, Greenberg PD, Appelbaum FR, Boyd CN, Buckner CD, Kaplan HG, Ramberg R, Sanders JE, Storb R, Thomas ED, Treatment of chronic granulocytic leukemia with chemoradiotherapy and
transplantation of marrow from identical twins, The New England Journal of Medicine, 306(2), 63-8, Jan 1982
 - Appelbaum FR, Fefer A, The pathogenesis of aplastic anemia, Seminars in Hematology, 18(4), 241-57, October 1981
 - Appelbaum FR, Fefer A, Cheever MA, Buckner CD, Greenberg PD, Kaplan HG, Storb R, Thomas ED, Treatment of non-Hodgkin's lymphoma with marrow transplantation in
identical twins, Blood, 58(3), 509-13, September 1981
 - Fefer A, Cheever MA, Thomas ED, Appelbaum FR, Buckner CD, Clift RA, Glucksberg H, Greenberg PD, Johnson FL, Kaplan HG, Sanders JE, Storb R, Weiden PL, Bone marrow transplantation for refractory acute leukemia in 34 patients
with identical twins, Blood, 57(3), 421-30, March 1981
 - Abrams RA, Glaubiger D, Appelbaum FR, Deisseroth AB, Result of attempted hematopoietic reconstitution using isologous,
peripheral blood mononuclear cells: a case report, Blood, 56(3), 516-20, Sep 1980
 - Appelbaum FR, Fefer A, Cheever MA, Sanders JE, Singer JW, Adamson JW, Mickelson EM, Hansen JA, Greenberg PD, Thomas ED, Treatment of aplastic anemia by bone marrow transplantation in identical
twins, Blood, 55(6), 1033-9, June 1980
 - Tosato G, Appelbaum FR, Trapani RJ, Dowling R, Deisseroth AB, Use of in vitro assays in selection of compatible platelet donors, Transfusion, 20(1), 47-54, Jan-F 1980
 - Flaum MA, Cuneo RA, Appelbaum FR, Deisseroth AB, Engel WK, Gralnick HR, The hemostatic imbalance of plasma-exchange transfusion, Blood, 54(3), 694-702, Sep 1979
 - Tosato G, Appelbaum FR, Deisseroth AB, Hla-matched platelet transfusion therapy of severe aplastic anemia, Blood, 54(1), 293, Jul 1979
 - Appelbaum FR, Hemopoietic reconstitution following autologous bone marrow and peripheral
blood mononuclear cell infusions, Experimental Hematology, 7 Suppl 5, 7-11, 1979
 - Appelbaum FR, Herzig G, Graw RG, Zeigler JL, Accelerated hemopoietic recovery following the infusion of cryopreserved
autologous bone marrow in humans, Experimental Hematology, 7 Suppl 5, 297-301, 1979
 - Gratwohl AA, Appelbaum FR, Levine AS, Ziegler JL, Deisseroth AB, [Long-term, complete remission in non-Hodgkin's lymphoma following
high-dosage combination therapy with or without autologous bone marrow
transplantation], Schweizerische Medizinische Wochenschrift, 108(49), 1961-3, Dec 1978
 - Appelbaum FR, Bowles CA, Makuch RW, Deisseroth AB, Granulocyte transfusion therapy of experimental Pseudomonas septicemia:
study of cell dose and collection technique, Blood, 52(2), 323-31, Aug 1978
 - Appelbaum FR, Herzig GP, Ziegler JL, Graw RG, Levine AS, Deisseroth AB, Successful engraftment of cryopreserved autologous bone marrow in patients
with malignant lymphoma, Blood, 52(1), 85-95, Jul 1978
 - Appelbaum FR, Deisseroth AB, Graw RG Jr, Herzig GP, Levine AS, Magrath IT, Pizzo PA, Poplack DG, Ziegler JL, Prolonged complete remission following high dose chemotherapy of Burkitt's
lymphoma in relapse, Cancer, 41(3), 1059-63, Mar 1978
 - Kramer BS, Appelbaum FR, Herzig GP, Graw RG Jr, Levine AS, Treatment of refractory acute leukemia with high-dose chemotherapy, Cancer Treatment Reports, 61(7), 1397-8, Oct 1977
 - Appelbaum FR, Trapani RJ, Graw RG Jr, Consequences of prior alloimmunization during granulocyte transfusion, Transfusion, 17(5), 460-4, Sep-O 1977
 - Appelbaum FR, Norton L, Graw RG Jr, Migration of transfused granulocytes in leukopenic dogs, Blood, 49(3), 483-8, Mar 1977
 - Slovak, M.L, Kopecky, K.J, Cassileth, D.H, Harrington, K.S, Theil, A.M, Paietta, E, Willman, C.L, Head, D.R, Rowe, J.M, Forman, S.J, Appelbaum, F.R., Karyotypic analysis predicts outcome of pre- and post-remission therapy in adult acute myeloid leukemia (AML): A SWOG (S9034)/ECOG (E3489) intergroup study, Blood, in pr
Profile DetailsIndividual Expertise profile of Frederick R. Appelbaum, Copyright Frederick R. Appelbaum. © COS Expertise TM, 2010, ProQuest LLC All rights reserved. |